Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Nov 11;16(11):e0259104. doi: 10.1371/journal.pone.0259104

Characterization of a new type of neuronal 5-HT G- protein coupled receptor in the cestode nervous system

Federico Camicia 1, Hugo R Vaca 2,3, Sang-Kyu Park 4, Augusto E Bivona 2,3, Ariel Naidich 5, Matias Preza 6, Uriel Koziol 6, Ana M Celentano 2,3, Jonathan S Marchant 4,*, Mara C Rosenzvit 2,3,*
Editor: Wolfgang Blenau7
PMCID: PMC8584985  PMID: 34762657

Abstract

Cestodes are platyhelminth parasites with a wide range of hosts that cause neglected diseases. Neurotransmitter signaling is of critical importance for these parasites which lack circulatory, respiratory and digestive systems. For example, serotonin (5-HT) and serotonergic G-protein coupled receptors (5-HT GPCRs) play major roles in cestode motility, development and reproduction. In previous work, we deorphanized a group of 5-HT7 type GPCRs from cestodes. However, little is known about another type of 5-HT GPCR, the 5-HT1 clade, which has been studied in several invertebrate phyla but not in platyhelminthes. Three putative 5-HT GPCRs from Echinococcus canadensis, Mesocestoides vogae (syn. M. corti) and Hymenolepis microstoma were cloned, sequenced and bioinformatically analyzed. Evidence grouped these new sequences within the 5-HT1 clade of GPCRs but differences in highly conserved GPCR motifs were observed. Transcriptomic analysis, heterologous expression and immunolocalization studies were performed to characterize the E. canadensis receptor, called Eca-5-HT1a. Functional heterologous expression studies showed that Eca-5-HT1a is highly specific for serotonin. 5-Methoxytryptamine and α-methylserotonin, both known 5-HT GPCR agonists, give stimulatory responses whereas methysergide, a known 5-HT GPCR ligand, give an antagonist response in Eca-5-HT1a. Mutants obtained by the substitution of key predicted residues resulted in severe impairment of receptor activity, confirming that indeed, these residues have important roles in receptor function. Immunolocalization studies on the protoscolex stage from E. canadensis, showed that Eca-5-HT1a is localized in branched fibers which correspond to the nervous system of the parasite. The patterns of immunoreactive fibers for Eca-5-HT1a and for serotonin were intimately intertwined but not identical, suggesting that they are two separate groups of fibers. These data provide the first functional, pharmacological and localization report of a serotonergic receptor that putatively belongs to the 5-HT1 type of GPCRs in cestodes. The serotonergic GPCR characterized here may represent a new target for antiparasitic intervention.

Introduction

The parasitic flatworms Echinococcus granulosus sensu lato (s.l.), Hymenolepis microstoma and Mesocestoides vogae (syn. M. corti) are tapeworms belonging to different families of the class Cestoda, with E. granulosus s.l. belonging to Taeniidae, H. microstoma to Hymenolepididae and M. vogae to Mesocestoididae family. Several species of the genus Echinococcus cause parasitic diseases in wildlife, domestic animals and humans worldwide. The larval stage of almost all species of the E. granulosus s.l. complex [which includes E. granulosus sensu stricto (s.s.) and E. canadensis] cause human cystic echinococcosis (formerly hydatidosis) [1], one of the 17 neglected diseases prioritized by WHO [2]. Parasites of the genus Hymenolepis are known to develop, depending on the species, in humans, rats and/or mice. H. nana is a highly prevalent human intestinal tapeworm, especially affecting children [3]. H. microstoma, the mouse bile duct tapeworm, is a rodent/beetle-hosted laboratory parasite that has been used as a model for the study of cestodes [4]. In recent years, the genome of H. microstoma has been sequenced and assembled [5]. M. vogae is a cestode that has a complex life cycle with arthropods as first intermediate hosts, mouse or lizards as second intermediate hosts and carnivores (dogs, cats or skunks) that host the adult intestinal tapeworms [6]. This parasite is a well-established model for laboratory studies [7] and is easy to maintain and reproduce. The larval stage (tetrathyridia) of M. vogae has a remarkable capacity of asexual reproduction in the peritoneal cavity of mice and some other mammalian hosts [8]. The tetrathyridium is used to examine drug effects on neuromuscular activity [9, 10].

The helminth nervous system plays essential functions in motility, chemosensation, reproduction, attachment, and feeding [11]. The importance of neuronal signaling events makes its component elements attractive targets for chemotherapy. For example, ligand-gated ion channels are already employed as drug targets in nematode treatment. G-protein coupled receptors (GPCRs) are also good examples of druggable targets for new compounds [11], as exemplified by the action of ligands that modulate the serotonergic system in flatworms [11]. The ability of anthelmintics to bind to GPCRs is supported by the finding that the antischistosomal drug praziquantel functions as a partial agonist of a human serotonergic GPCR [12]. In mammals, seven major types of 5-HT receptors are known but in invertebrates, only three types or clades have been found [13]. The invertebrate receptors are classified according to homology with mammalian receptor families as 5-HT1, 5-HT2 and 5-HT7-like, being the classified system followed in this work. 5-HT1 type activated receptors are preferentially coupled with the alpha subunit of an inhibitory G-protein (Gαi/o) which inhibits adenylate cyclase [13]. Activation of 5-HT2 type receptors are usually characterized by a rise in cytoplasmic calcium following the activation of Gαq/11 [13]. Finally, the 5-HT7 type, include receptors which are preferentially coupled with Gαs leading to the activation of adenylate cyclase and an increase in intracellular cyclic AMP [13]. In previous works, several serotonergic GPCRs were identified in cestodes [5, 14]. However, at the time of writing, all the serotonergic GPCRs functionally reported from platyhelminths, are grouped within type 7 serotonergic GPCRs [10, 1518]. Genome searches predicted the presence of additional 5-HT GPCRs in platyhelminths [15, 16]. In nematodes, it is well known that 5-HT1 type receptors play major roles in motor control [19] and in some parasitic nematode species it has been shown that 5-HT1 agonists could be used as anthelmintic agents [20]. In recent years, Wang & coworkers [21] reported the crystal structures of the human (Homo sapiens) Hsa-5-HT1b GPCR when bound to the ergot alkaloids ergotamine and dihydroergotamine. These drug bound structures reveal the important roles of critical motifs and specific amino acid residues in transmembrane domains 3 and 5 (besides others) that form the orthosteric pocket or ligand binding site of the receptor. Another important structural breakthrough was the report of the first molecular structure of the serotonin Hsa-5-HT1b receptor coupled to heterotrimeric Gαo [22].

In this work, we report for the first time, the cloning, sequencing and bioinformatic characterization of a new 5-HT GPCR type, that likely belongs to the 5-HT1 class (clade 4), in several species of cestodes. We functionally characterize and localize one of these 5-HT1 type GPCRs from E. canadensis which shows a particular pharmacology. Moreover, mutant analyses seem to confirm pivotal roles played by some residues located at specific positions in the receptor´s sequence. Our results demonstrate that this GPCR is present in the cestode nervous system, where it may play a role in neuromuscular function, making it a viable target for future chemotherapeutic intervention.

Material and methods

Ethics statement

Experiments involving the use of experimental animals were carried out according to protocols approved by the Comité Institucional para el Cuidado y Uso de Animales de Laboratorio (CICUAL), Facultad de Medicina, Universidad de Buenos Aires, Argentina (protocol “Farmacología, localización y función de receptores acoplados a proteínas G (GPCRs) y de canales de calcio de Echinococcus granulosus y otros parásitos cestodes como posibles blancos de drogas antiparasitarias” CD N° 2542/2019). For M. vogae passages, the protocol “Pasaje in vivo de parásitos cestodes de la especie Mesocestoides corti” CD N°1127/2015 and 1229/2015 was followed. Cyst puncture was performed following the approved protocol by the same institution (protocol “Punción de quistes hidatídicos de infecciones naturales” CD N° 3723/2014). H. microstoma passages were performed according to the protocol “Mantenimiento del ciclo vital completo del cestodo Hymenolepis microstoma utilizando sus hospedadores naturales Mus musculus (ratón) y Tribolium confusum (escarabajo de la harina)”; Protocol number: 10190000025215, Comisión Honoraria de Experimentación Animal, Uruguay.

Chemicals

5-HT (H9523), α-methylserotonin (M110), 5-methoxytryptamine (286583), tryptamine (193747), tyramine (T90344), octopamine (O0250), acetylcholine (A6625), histamine (H7125), dopamine (H8502) and methysergide (M137) were obtained from Sigma Chemical Company. Tryptamine, α-methylserotonin, 5-methoxytryptamine and methysergide were dissolved in DMSO whereas tyramine, octopamine, acetylcholine, histamine and dopamine were dissolved in distilled H2O, all of them (with the exception of 5-HT) at 100 mM. 5-HT was dissolved in distilled H2O at stock concentration of 5 mM. Stock solutions were either made up on the day of the experiment or taken from aliquots stored at -80°C for no longer than 1 week prior to use. After 0.22 μm filtration with Millex GV filter units (Millipore, Ireland), stock solutions were diluted to the corresponding final concentration (e.g. 0.0001; 0.001; 0.01; 0.1; 1; 10 and 50 μM for 5-HT) in RPMI medium with high glucose (Gibco, USA).

Animals

Wistar female rats and BALB/c female mice were bred and housed at the animal facilities of Instituto de Investigaciones en Microbiología y Parasitología Médica (IMPaM), Facultad de Medicina, Universidad de Buenos Aires (UBA)-Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina, in a temperature-controlled light cycle room with food and water ad libitum. C57BL/6 female mice were bred and housed in collaboration with Jenny Saldaña and Laura Domínguez, Laboratorio de Experimentación Animal, Facultad de Química, Universidad de la República, Uruguay. Experiments with animals were approved by the Review Board of Ethics of the School of Medicine (UBA, Argentina) and conducted in accordance with the guidelines established by the National Research Council.

Parasite material

E. granulosus s.l. protoscoleces were obtained under sterile conditions by needle aspiration of hepatic hydatid cysts of porcine origin. Parasite material was kindly donated by Alimentaria La Pompeya, Marcos Paz, Provincia de Buenos Aires, Argentina. The livers used for parasite extraction were from animals that were not specifically used for this study and all the material obtained was processed as part of the normal work of the abattoir. Samples from animals at the abattoir were collected under consent from local authorities. Protoscolex viability was assessed using the eosin exclusion test after three washes with PBS, with 50 μg/ml of gentamicin to remove cyst wall debris [23]. Only samples showing more than 95% viability were used. A fraction of the protoscoleces was used for whole mount immunohistochemistry, another fraction was used for cDNA synthesis and the remaining protoscoleces were used for species/genotype determination by sequencing a fragment of the mitochondrial cytochrome c oxidase subunit 1 (CO1), as previously described [24]. The resulting species and genotype of all protoscoleces used in this work were from E. canadensis G7. Three biological replicates were used with each replicate corresponding to protoscoleces obtained from a single cyst. M. vogae larvae (tetrathyridia) were maintained by alternate, serial passages in Wistar female rats and BALB/c female mice as previously described [6]. The tetrathyridia larvae were obtained from the mouse intraperitoneal cavity after 3 months of intraperitoneal inoculation. Only tetrathyridia from up to the third serial passage in mice were used for the experiments. The life cycle of H. microstoma was maintained using C57BL/6 mice as definitive hosts, and Tribolium confusum beetles as intermediate hosts [4]. Adults were obtained from the bile duct of infected mice after 3 to 4 months post-infection.

Bioinformatic analyses

The selection of the sequences for the cloning of E. canadensis, H. microstoma and M. vogae 5-HT1 GPCRs were based on bioinformatic analysis done by our group previously to this work [5, 10, 14]. Transmembrane segments were predicted using the topology prediction server HMMTOP (http://www.enzim.hu/hmmtop/index.php) and bidimensional models of receptors were generated using Protter (http://www.enzim.hu/hmmtop/index.php). Analyses of critical residues for serotonergic GPCR ligand binding, G-protein coupling and clade characterization were performed using only platyhelminth sequences from different serotonergic clades and aligned using ClustalW program from the expasy proteomic package (https://embnet.vital-it.ch/software/ClustalW.html). The Ballesteros and Weinstein (B&W) nomenclature for residue numbering was followed here [25]. For the search of best orthologues, blast searches were performed in wormbase parasite (https://parasite.wormbase.org/index.html) and only sequences with at least 70% of amino acid identity were chosen for the alignment. Only some gene models were chosen for the alignment, which also gave the best alignments by visual inspection in multiple sequence alignments. The protein sequence alignments were performed using ClustalW alignment utility integrated to MEGA X software [2628]. Trees were built according to the Neighbour-Joining method using the Best Tree mode available in MEGA X and were verified by bootstrap analysis with 500 replicates. Cloned and sequenced Eca-5-HT1a, Mvo-5-HT1a and Hmi-5-HT1a were aligned with serotonin receptor sequences from the following invertebrates: E. canadensis, M. vogae, Dugesia japonica, Schistosoma mansoni, Caenorhabditis elegans and Drosophila melanogaster. With the exception of most of the sequences from D. japonica and S. mansoni, the rest of the sequences used for Phylogenetic groupings and multiple sequence alignments in tables were from receptors functionally tested and with G- protein coupling partners determined. The tree drawing was obtained using FigTree v 1.4.4 [29]. For prediction of coupling specificity, the web server program PRED COUPLE 2.00 was used (http://bioinformatics.biol.uoa.gr/PRED-COUPLE) [30, 31]. The predictive capacity of the program was previously tested using ten sequences from serotonergic receptors belonging to different invertebrate species for which coupling specificity was experimentally determined (S1 Table). In all the cases tested, we found a perfect match between the G-protein coupling partner experimentally determined and the predicted by the program.

Levels of GPCR expression

The transcriptional expression levels (in RPKM, or reads per kilobase per million reads) for each serotonergic receptor in E. granulosus s.s. (G1 genotype) were from Zheng et al. [32].

Homology modeling

For molecular homology modeling studies, protein domains of the 5-HT1-type receptors studied in this work (Eca-5-HT1a, Mvo-5-HT1a and Hmi-5-HT1a), the 5-HT7-type receptors Eca-5-HT7a and Mvo-5-HT7a, studied previously [10], and the 5-HT7-type receptor from H. microstoma (Hmi-5-HT7a; Wormbase parasite gene ID HmN_000156500) were screened against PFAM databases, using PfamScan [33]. Protein structure homology models were performed using PHYRE2 [34] and SWISS-MODEL [3537] databases. For all sequences, already crystallized structures from H. sapiens (PDB IDs: 4IAQ and 4IAR) [21] were used as templates for modeling seven transmembrane domains. The intracellular loop 3 (ICL3) and C-terminus (C-term) regions were modeled ab initio using PHYRE2. The homology model for the human receptors Hsa-5-HT1a (P08908) and Hsa-5-HT7a (P34969) were also performed. The molecular visualization and figures generated in this work were performed using the software PyMOL version 2.0.4 (https://pymol.org). All homology models obtained were validated calculating several parameters such as: ERRAT [38] (https://servicesn.mbi.ucla.edu/ERRAT/), QMEN and Ramachandran plots, which were calculated using Structure Assessment Tool of SWISS-MODEL (https://swissmodel.expasy.org/assess). RMSD and TM-align [39] (https://zhanglab.ccmb.med.umich.edu/TM-align/) were determined to compare the homology models to Hsa-5-HT1b (PDB ID: 4IAR). Finally, structural comparisons were performed to identify relevant and conserved residues in the ligand binding site and G- protein interaction site.

RNA extraction and cDNA synthesis

Total RNA from E. canadensis was isolated from protoscoleces that were crushed under liquid nitrogen and processed using Trizol reagent (Invitrogen). The RNA obtained was treated with RNase-Free DNase (Fermentas), ethanol precipitated and reverse transcribed using Superscript III reverse transcriptase (RT) (Invitrogen) and gene specific reverse primer complementary to 5-HT GPCR gene models. One cDNA for each selected gene model was synthesized. The same procedure was followed to obtain RNA from M. vogae tetrathyridia and cDNA synthesis. Total RNA from H. microstoma was isolated from adult stage obtained from the bile ducts of C57BL/6 mice and purified with TRI Reagent (Sigma Aldrich) in combination with the Direct-zol RNA Miniprep (Zymo Research). Reverse transcription was performed with Superscript II (Invitrogen) according to the instructions of the manufacturer.

Amplification and cloning of cDNAs coding for serotonergic GPCRs

The gene model called EgrG_001050800.1 from E. granulosus s.s. was first identified by reciprocal BLAST searches [14] from the published genome of E. granulosus [5]. Using primers against the contiguous regions to the ends of the coding region of this receptor-coding gene and employing cDNA from E. canadensis, the full-length cloning of this cDNA was accomplished. The sequence of the forward primer was 5´ CAGCGTGCTGAGGTGCCAATC 3´ and that of the reverse primer was 5´ GAGTTGTGGGGACAAGGTTGC 3´. The product obtained by PCR amplification using Q5® High-Fidelity DNA Polymerase (New England Biolabs) had the expected size (~1900 base pairs, bp). The cycling parameters for the PCR were: initial denaturing step 98 degrees, 30 seconds followed by 35 cycles of the following steps: melting, 98°C, 10 seconds; annealing 66°C, 30 seconds and extension, 72°C, 2,5 minutes; the amplification finished with a final extension step of 30 minutes at 72°C. For M. vogae, the gene model called MCU_000790-RA was identified by BLAST searches of the predicted proteome of this species [40] using the sequence from E. canadensis as a bait. Using primers against the contiguous regions to the ends of the coding region of this receptor and employing cDNA from M. vogae, the full-length cloning was later accomplished. The sequence of the forward primer was 5´ GATTAATGCCTCCACTCACAC 3´ and that of the reverse primer was 5´ GTCTGCTTTCGTCACTTAAAGTAG 3´. Using these primers in PCR amplification with Q5® High-Fidelity DNA Polymerase (New England Biolabs) an amplification product of the expected size (~1900 bp) was obtained. The cycling parameters for the PCR were: initial denaturing step 98°C, 30 seconds; followed by 35 cycles of the following steps: melting, 98°C, 10 seconds; annealing 60°C, 30 seconds and extension, 72°C, 2,5 minutes; the amplification finished with a final extension step of 30 minutes at 72°C. For H. microstoma, the gene model called HmN_000578900 was identified by BLAST searches using the sequence from E. canadensis as a bait. The forward primer sequence was 5-ATGGCGGCCACAGTTTCTC-3 and the reverse primer was 5-ATCGAAAACAATTCAATCGTG-3. Both primers gave an expected product size (1824 bp) by PCR amplification using High Taq DNA polymerase (Bioron, Germany). The cycling parameters for the PCR were: initial denaturation 94°C, 2 minutes; followed by 30 cycles of the following steps: melting, 94°C, 10 seconds; annealing, 52°C, 20 seconds; elongation, 72°C, 2 minutes. The protocol finished with a final extension step at 72°C, 30 minutes. Amplification products were visualized by agarose gel electrophoresis and Gel Red staining and the bands of interest were extracted from the gel using the QIAquick Gel Extraction Kit (Qiagen) and cloned into the pTOP Blunt cloning vector (Macrogen). The recombinant plasmids were used for Escherichia coli (DH5α) transformation and the transformed bacteria were grown in LB medium with ampicillin and kanamycin. The selected colonies were then used for plasmid purification using the GeneJet Plasmid miniprep kit (Fermentas) and sequencing using an Applied Biosystems Big Dye terminator kit (Applied Biosystems) on an ABI 377 automated DNA sequencer. The cloned cDNAs from E. canadensis, M. vogae and Hymenolepis microstoma were named Eca-5-HT1a, Mvo-5-HT1a and Hmi-5-HT1a respectively.

Fluorescence Imaging Plate Reader (FLIPR) assay

HEK293 cells (ATCC CRL-1573.3) or Gα15 stably transfected HEK293 cells (HEK293-Gα15) were cultured in growth media [DMEM (Gibco), 10% heat inactivated fetal bovine serum (Gibco), penicillin (100 units/mL), streptomycin (100 μg/mL) and L-glutamine (290μg/mL)] and used for assays between passages 5 and 25. For cestode GPCR heterologous expression assays, cells were transfected (Lipofectamine 2000, Invitrogen) at 80% confluency approximately 16 hours after seeding within 60 mm plate dish with 6 μg of plasmid DNA of human codon optimized cestode GPCR cDNA (subcloned into a pcDNA3.1(-) mammalian expression vector). The following day, cells were trypsinized, centrifuged (300g/5min), resuspended in DMEM supplemented with 1% dialyzed FBS (Gibco) and plated in 96 well, black-walled clear-bottomed poly-d-lysine coated 96-well plate (Corning). Cells were seeded (50,000 cells/well) in DMEM growth media with 10% dialyzed FBS and allowed to adhere. After 24 hours, growth medium was removed, and 100 μl of 1× Fluo-4 NW dye loading solution (Invitrogen), which was reconstituted with an assay buffer containing 2.5 mM probenecid in 1× Hanks’ balanced salt solution (HBSS) with Ca2+, Mg2+, and 20 mM HEPES was added to each well. The cells were incubated for 30 min at 37°C in 5% CO2 in air followed by an additional 30-min incubation at room temperature. Dilutions for each drug were prepared in RPMI medium, without probenecid and dye, in V-shape 96-well plates (Greiner Bio-one, Germany). The calcium assay was performed at room temperature using a FLIPRTETRA (Molecular Devices). Basal fluorescence was monitored for 20 s, then 25 μl of each drug was added, and the signal was monitored over 250 seconds. Results were expressed as relative fluorescence units (RFU). At the end of [Ca2+]i measurements, cells were examined for morphological changes. Data analyses were performed using Excel and Origin to yield the EC50 parameter (half maximal effective concentration). Controls consisted of mock transfected HEK293-Gα15 cells and HEK293 cells.

Design of mutants for Eca-5-HT1a

Four different plasmid constructs were designed by request in Genscript company replacing native residues from Eca-5-HT1a by alanine. The mutants designed were: glutamate replaced by alanine (D118A), cysteine by alanine (C122A), threonine by alanine (T123A) and finally tryptophan by alanine (W542A). Each of the four mutants for cestode GPCR was subcloned into a pcDNA3.1(-) mammalian expression vector and used for HEK293-Gα15 cell transfection. Mutants and wild type Eca-5-HT1a calcium responses were compared. Data analyses were performed using Excel and Origin to yield the EC50 parameter (half maximal effective concentration).

Cell transfection with Eca-5-HT1a and cell line generation

HEK293 cells (1 × 106) stably expressing GNA15 (HEK-GNA15) were seeded into 60 mm dishes and after 24 hours were transfected with 5 μg of plasmid DNA, pCMV6-A-Puro Eca-5-HT1a (Eurofins Blue Heron Biothech) by using Lipofectamine 2000 reagent. Forty-eight hours after transfection, cells were trypsinized and seeded into 100-mm dishes and selected by 200 μg/ml hygromycin and 2 μg/ml puromycin for 7–10 days. Single colonies were isolated, and the expression of Eca-5-HT1a was examined by FLIPRTETRA.

Bacterial expression of the third intracellular loop of Eca-5-HT1a and preparation of polyclonal antibodies

The sequence from the nucleotide position 673 to 1581 of the cDNA that encodes for a protein fragment of 303 amino acids which represent the entire ICL3 of Eca-5-HT1a receptor was codon optimized and the nucleotide fragment synthesized (Eca-5-HT1aICL3, S1 Text). The synthesized sequence was cloned into the vector pET-30a (+) with His tag for protein expression. E. coli strain BL21 star (DE3) was transformed with the recombinant plasmid mentioned above. Recombinant BL21 star (DE3) stock stored in glycerol was thawed and inoculated in 4 ml LB medium containing 50 μg/ml kanamycin and incubated overnight at 37°C with shaking at 200 rpm. The 4 ml pre-culture was seeded into 2 X 500 ml Terrific Broth Liquid microbial growth medium containing 50 μg/ml kanamycin in a 2 liters Erlenmeyer flask, and incubated at 37°C with shaking at 200 rpm. When the OD600 value of the culture reached 1.2, IPTG was added at final concentration of 0.5 mM to induce protein expression at 15°C for 16h with shaking at 200 rpm. Cells were harvested by centrifugation at 8,000 g at 4°C for 20 min. Cell pellets were resuspended with lysis buffer (50 mM Tris-HCl,150 mM NaCl, 1mM DTT, pH 8.0) followed by sonication cycles consisting of alternating 3 seconds on and 6 seconds off for a total of 6 min at 600 w. The precipitate after centrifugation was dissolved using a denaturing agent (50 mM Tris-HCl, 8M Urea, 1mM DTT, pH 8.0). Eca-5-HT1aICL3 protein was obtained by one-step purification using Ni2+ column and eluted with elution buffer (50 mM Tris-HCl, 8M Urea, 500 mM Imidazole, pH 8.0). Target protein was pooled and refolded by dialyzing into buffer PBS, 10% Glycerol, 0.2% SDS, pH 7.4. After dialysis, the sample was filtered through a 0.22 μm filter. The concentration was determined by BCATM protein assay (ThermoFisher, Cat. No. 23225) with bovine serum albumin as standard. The protein purity was around 85% as estimated by densitometric analysis of the Coomassie Blue-stained SDS-PAGE gel under reducing conditions. The molecular weight observed was approximately 40 kDa and close to the predicted molecular weight, as determined by standard SDS-PAGE along with Western blot confirmation (S1A Fig). Western blots were performed using “THE™ His-Tag Antibody, mAb, Mouse” as primary antibody (GenScript, Cat. No. A00186) and revealed using rabbit anti-mouse IgG H&L (HRP) (ab6728) as secondary antibody. Six-week-old female Balb/c mice (n = 6) were immunized four times (on days 0, 10, 20 and 30) with 20 μg of the recombinant Eca-5-HT1aICL3 (S1 Text) by intraperitoneal injection. Priming dose was administered with complete Freund’s adjuvant (Sigma-Aldrich) and subsequent doses were formulated with incomplete Freund’s adjuvant (Sigma-Aldrich). Fifteen days after the last immunization, mice were exsanguinated under general anesthesia and then euthanized by cervical dislocation. Blood was allowed to coagulate at 37°C for 30 min and finally serum was separated by centrifugation at 2000 g for 10 min. Anti-Eca-5-HT1a titers in serum were determined by ELISA (S1B Fig). Briefly, a 96-well flat bottom polystyrene plate (Nunc, Thermo Scientific) was coated with 0.2 μg of recombinant Eca-5-HT1aICL3 per well O.N. at 4°C. Then, non-specific binding sites were blocked with a solution of 3% BSA in PBS for 2 h at 37°C. After washing the plate three times with 0.05% Tween-20 solution, 2-fold serial dilution of mice sera were incubated O.N. at 4°C (pre-immune serum was included as negative control). Next day, the plate was washed again and an anti-IgG-HRP (Sigma B6398) antibody (1/10000 dilution) was added as secondary antibody and incubated for 1 h at 37°C. After washing again, the assay was revealed with TMB (tetramethylbenzidine, BD OptEIA™) and the reaction was stopped 15 min later with 4 N H2SO4. Absorbance at 450 nm was determined on an ELISA plate reader (Labsystems Multiscan EX). Specific antibody end-point titer was calculated as the reciprocal of the dilution with an Absorbance 450nm = 0.5.

Whole-mount immunohistochemistry

Freshly obtained protoscoleces of E. canadensis from porcine hydatid cysts were activated by treatment with pepsin in DMEM (0.05% W/V) under acidic conditions (pH = 2) for 1 hour at 37°C with shaking (125 rpm). Then, they were allowed to sediment, washed three times with PBS and treated with sodium taurocholate (0,2% W/V, checking that the pH remains at 7.4) for three hours at 37°C with shaking (125 rpm). Finally, the protoscoleces were washed again 3 times with PBS. After washing, the viability of protoscoleces was checked with the eosin exclusion test and, if they had more than 95% viability, they were fixed overnight with 4% paraformaldehyde at 4°C with shaking. After fixation, protoscoleces were washed three times with PBS-T at room temperature with shaking. The Immunohistofluorescence protocol of Koziol [41] for whole-mounts (WMIHF) without proteinase K treatment was then followed with minor modifications. Antibodies were used at the following dilutions: 1/50 for anti-Eca-5-HT1a, 1/100 for anti-5-HT produced in rabbit (IgG whole molecule, catalog number S5545, Sigma) and 1/600 for anti-tropomyosin antibody produced in rabbit [42]. This latter antibody was a kind gift of Dr Gabriela Alvite, Sección Bioquímica, Universidad de la República, Uruguay. Secondary antibodies were IgG (H+L) Goat anti-Rabbit conjugated to FITC from Invitrogen™ and Goat anti-Mouse IgG (H+L) Secondary Antibody conjugated to Rhodamine, from ThermoFisher ScientificTM and both antibodies were used at 1/200. Specimens were finally mounted in a mix of 80% glycerol and 50 mM Tris-HCl, pH 8. Samples were viewed by a Spinning Disk-TIRF-Olympus-IX83 motorized microscope with confocal module (Disk Spinning Unit) coupled to a Hamamatsu Orca Flash 4 digital camera of 16 bits and a confocal Zeiss LSM 880 microscope with Airyscan detector for super-resolution. Images were captured at the best resolution possible (2048 x 2048). Images and stacks were viewed and processed using FIJI software (version 2.0.0-rc-69/1.52p).

Results

A new type of cestode serotonergic GPCR was cloned and bioinformatically analyzed

Based on previous bioinformatics analyses by our group [5, 10, 14], we cloned and sequenced a putative 5-HT1 GPCR receptor from E. canadensis. The cloned sequence was highly similar (~98% identity) but not identical to gene model EcG7_02049 from the published genome of E. canadensis [43] and was 1866 bp long with an open reading frame of 1821 bp, which encode a hypothetical receptor that was called here Eca-5-HT1a.

According to the gene model (EcG7_02049) available in the Wormbase parasite database (https://parasite.wormbase.org/index.html), the gene sequence has three exons separated by two alternating introns. According to transcriptomic data available from the genome project of Zheng and coworkers [32], the messenger encoding for the E. granulosus s.s. orthologue of this receptor is highly expressed and restricted to the protoscolex stage (S2 Fig). Multiple sequence alignment with other orthologous sequences strongly suggested that the sequence found was complete. The predicted amino acid sequence is 606 residues long with a deduced molecular weight of 68,9 kDa. A program used to predict N-linked glycosylation (Protter) marked one potential site of N-linked glycosylation at the N-terminal end (Fig 1A). The Eca-5-HT1a receptor was highly conserved in other cestode species. Hypothetical orthologues of this receptor were also cloned and sequenced in M. vogae and H. microstoma (Fig 1B). The three cloned receptors grouped within the 5-HT1 clade (Fig 1C) were named as “Eca-5-HT1a”, “Mvo-5-HT1a” and “Hmi-5-HT1a” from serotonergic type 1 receptors from E. canadensis, M. vogae and H. microstoma respectively.

Fig 1. Bioinformatic analyses of the three 5-HT1 serotonin receptors identified in this work (Eca-5-HT1a, Mvo-5-HT1a and Hmi-5-HT1a, GenBank accession numbers MW535743, MW535744 and MW535745 respectively).

Fig 1

A. The structural representation and prediction of residues of potential N-glycosylation of Eca-5-HT1a were obtained with the Protter program (http://www.enzim.hu/hmmtop/index.php). The intracellular and extracellular loops are indicated as ICL and ECL respectively. The third intracellular loop used for antibody generation is shaded in grey. Residues potentially involved in N-linked glycosylation were marked in green. B. The amino acid sequences of predicted serotonin receptors ortologues with best scores in blast searches with the cestode Eca-5-HT1a were aligned using the ClustalW method. The new 5-HT1 type cloned receptors’ names are marked in bold and aligned against sequences of orthologous receptors from Hydatigera taeniaeformis (Hta-5-HT1a, gene model number TTAC_0000125301), Taenia asiatica (Tas-5-HT1a, gene model number TASK_0000705401), Hymenolepis nana (Hna-5-HT1a, gene model number HNAJ_0000723201), Echinococcus granulosus (Egr-5-HT1a, gene model number EgrG_001050800.1), Taenia saginata (Tsa-5-HT1a, gene model number TSAs00002g00673m00001), Echinococcus multilocularis (Emu-5-HT1a, gene model number EmuJ_001050800.1), Taenia solium (Tso-5-HT1a, gene model number TsM_000928200), Hymenolepis diminuta (Hdi-5-HT1a, gene model number HDID_0000514801), Taenia multiceps (Tmu-5-HT1a, gene model number Tm1G003304), Schistocephalus solidus (Sso-5-HT1a, gene model number SSLN_0001996401), Dibothriocephalus latus (Dla-5-HT1a, gene model number DILT_0000437701), Spirometra erinaceieuropaei (Ser-5-HT1a, gene model number SPER_0002466701) and Gyrodactylus salaris (Gsa-5-HT1a, gene model number scf7180006953168). The transmembrane (TM), intracellular (ICL) and extracellular (ECL) domains are indicated above each alignment. For the sake of simplicity, the amino terminal end, the intracellular loop three and the carboxy terminal end were trimmed partially or completely. The position of residues involved in G-protein coupling are indicated with asterisks below each alignment. Residues present in the new predicted receptors that were not seen in other GPCRs are underlined. Critical residues involved in ligand binding and receptor function were indicated in bold below each alignment. Cysteine residues potentially involved in disulphide bond formation are marked as S-S between cysteines. The reader is referred to the S1 Table for the complete list of receptor names, species and identification numbers. C. The amino acid sequences of predicted cestode serotonin receptors were aligned with a repertoire of serotonin receptors cloned from Echinococcus canadensis (Eca-5-HT1b, gene model EcG7_00799; Eca-5-HT7a and Eca-5-HT7b, Genbank accession numbers MH707372 and MH707373 respectively), Mesocestoides vogae (Mvo-5-HT7a, Genbank accession numer MH707374), Dugesia japonica (Dja-5-HT1a to Dja-5-HT1e, Dja-5-HT2a to Dja-5-HT2c and Dja-5-HT7a to Dja-5-HT7h; PMID PMC4569474), Schistosoma mansoni (Sma-5-HT1 and Sma-5-HT7b, Genbank accession numbers XP_018645423 and KX150867 respectively), Caenorhabditis elegans (Cel-5-HT1, Cel-5-HT2 and Cel-5-HT7, Uniprot accession numbers G5EGH0, O17470 and Q22895 respectively) and Drosophila melanogaster (Dme-5-HT1a, Dme-5-HT1b, Dme-5-HT2a, Dme-5-HT2b and Dme-5-HT7, Genbank accession numbers CAA77570.1, CAA77571.1, CAA57429.1, NP_001262373.1 and NP_524599.1 respectively). The alignment included representative examples of the three major classes of serotonergic GPCRs from invertebrates. These include type 2 serotonin receptors (5-HT2, blue), type 7 (5-HT7, green) and type 1 receptors (5-HT1, red). The cestode GPCR sequences cloned and functionally expressed in this study (name labels shaded in gray: Eca-5-HT1a, Mvo-5-HT1a and Hmi-5-HT1a) as well as the putative receptor identified in databases (name label shaded in gray: Eca-5-HT1b) cluster within a clade of 5-HT1 like receptors. The FMRFaR neuropeptide receptor from D. melanogaster (DmeFMRFaR, Uniprot accession number Q9VZW5) was used as outgroup. The tree was tested by bootstrap analysis with 500 iterations. The length of the branches is proportional to the genetic distance between sequences (see scale bar).

The predicted topology of these three cestode receptors comprised the canonical fold of seven transmembrane domains (7TM), with an extracellular amino terminal end, an intracellular carboxy terminal end and three alternating intracellular (ICLs) and extracellular (ECLs) loops (Fig 1A). The cestode sequences obtained here were aligned with hypothetical orthologues found in several plathyhelminth species, most of them in cestodes (Fig 1B).

This analysis suggests a strong degree of conservation of this hypothetical receptor in several platyhelminth species. Many residues involved in ligand binding, receptor activation and receptor G-protein coupling are conserved (Fig 1B). The new cestode receptors grouped within the 5-HT1 clade of serotonergic receptors in the phylogenetic tree (Fig 1C). This type of receptor is usually characterized by Gαi/o coupling upon ligand activation and an inhibitory effect on cAMP production.

We have also retrieved another sequence (EcG7_00799) from the E. canadensis genome belonging to the 5-HT1 type christened Eca-5-HT1b (S3 Fig). The nucleotide sequence of the cDNA for this gen was 1638 bp long with an open reading frame of 1638 bp. The gene has three coding exons separated by two introns. Similar to Eca-5-HT1a, multiple sequence alignments with other orthologous sequences suggested that Eca-5-HT1b is also complete. The predicted amino acid sequence is 545 residues long with a deduced molecular weight of 61.2 kDa. The prediction of N-linked glycosylation site, marked one potential site of N-linked glycosylation at the N-terminal end (S3A Fig). The hypothetical Eca-5-HT1b receptor was also conserved in other cestode species (S3B Fig). In a similar way to Eca-5-HT1a, Eca-5-HT1b grouped within the 5-HT1 clade (Fig 1C). The predicted topology of this cestode receptor comprised the canonical fold of seven transmembrane domains (7TM), with an extracellular amino terminal end, an intracellular carboxy terminal end and three alternating ICLs and ECLs (S3A Fig). However, this annotated receptor was not examined experimentally.

For labelling important amino acid residues, the Ballesteros and Weinstein nomenclature for amino acid residue numbering was followed [25]. Most of the residues identified as having major roles in mammalian GPCR function are conserved in invertebrate sequences (Table 1). Residues involved in ligand binding in mammalian serotonin GPCRs were conserved, including aspartate residue D3.32 (the carboxylate group of which stabilizes the ligand in the orthosteric pocket) and V3.33, C3.36, W6.48 and F6.51 (the side chains of which form a narrow hydrophobic cleft important for ligand recognition). Moreover, the indole N-H hydrogen of 5-HT forms a hydrogen bond with the threonine residue T3.37, which is also conserved. Examples of residues conserved in other GPCRs but not exclusively in serotonergic GPCRs are the cysteine of the third transmembrane domain and the cysteine present in the ECL 2 that partially covers the ligand binding pocket (C3.25-CECL2) [21]. The highly conserved NPxxY motif toward the cytoplasmic end of TM7 involved in GPCR activation [44] is also conserved in the cestode GPCR sequences (Fig 1B).

Table 1. Important amino acid residues in ligand binding and receptor activation of the cloned cestode GPCRs and homologous invertebrate GPCRs.

TM 3 ICL 2 ECL 2 TM 5 TM 6
Hsa-5-HT1b F3.28 I3.29 D3.32 V3.33 C3.36 T3.37 I3.40 D3.49 R3.50 Y3.51 CECL2 T5.39 S5.42 A5.46 F6.44 W6.48 F6.51 F6.52 A6.55 L6.57
Eca-5-HT1a W I D V C T T E R C C T S A F W F N A L
Mvo-5-HT1a W I D V C T T E R C C T S A F W F N A L
Hmi-5-HT1a W I D V C T T E R A C T S A F W F N A L
Eca-5-HT1b W I D V C T I D R Y C T S S F W F S A V
Dja-5-HT1a W V D V C S I D R Y C T S A F W F F A I
Dja-5-HT1c W I D V C T I D R Y C I A S F W F G N L
Sma-5-HT1 W I D V C T I D R Y C T S A F W F F T I
Dja-5-HT2b W Y D V T S I D R Y G I A T F Y F F Y L
Dja-5-HT2c W Y D V T A I D R Y G I A T F Y F F Y C
Eca-5-HT7a Y S D V C T I D R Y C Q A A F W F F Q I
Eca-5-HT7b F I D V C T I D R Y C Q A A F W F F A G
Mvo-5-HT7a Y N D V C T I D R Y C Q A A F W F F Q I
Dja-5-HT7a Y N D V C T I D R Y C Q A A F W F F Q L
Dja-5-HT7f F I D V C S I D R Y C Q A A F W F F Q I
Sma-5-HT7b Y I D V C T I D R Y C Q A A F W F F Q L

Important residues usually present in receptors of the 5-HT1 type but not commonly observed in other receptor clades were marked in bold. Receptors analyzed in this study were shaded in grey. TM indicates the number of transmembrane domain, ICL, the number of Intracellular loop and finally, ECL, the number of extracellular loop in each receptor.

Table 1 summarizes critical amino acid residues at the indicated positions (B&W nomenclature) in the human Hsa-5-HT1b receptor. Corresponding residues in invertebrate GPCR sequences are shown, including the GPCRs cloned here (marked in bold in the left), 5-HT1, 5-HT2 and 5-HT7 receptors from Dugesia japonica (Dja-5-HT), 5-HT1 and 5-HT7 receptors from Schistosoma mansoni (Sma-5-HT), 5-HT1 and 5-HT7 receptors from Echinococcus canadensis (Eca-5-HT) and finally, the 5-HT7 receptor from Mesocestoides vogae (Mvo-5-HT7a).

The presence of certain residues at defined positions in cestode GPCR sequences (Table 1) suggests that the identified sequences belong to the 5-HT1 class. For example, in invertebrates the tryptophan at the aromatic residue position 3.28 occurs only in 5-HT1 and 5-HT2 receptors but not in the 5-HT7 type GPCRs where mostly tyrosine or phenylalanine residues are present. The cysteine and threonine at positions 3.36 and 3.37 respectively seem to be more frequent in the 5-HT1 and 5-HT7 type than in the 5-HT2 type receptors. Residues at positions 5.42 and 5.46, both in the orthosteric binding pocket, were previously defined as diagnostic of the different serotonergic clades for planarians [15]. Fig 1 and Table 1 show the presence of serine/alanine at the positions 5.42 and 5.46 respectively in TM5 in the three identified cestode GPCRs and in other invertebrate 5-HT1 receptors, which also suggest that they belong to the 5-HT1 class. The Eca-5-HT1b receptor harbors a serine residue at position 5.46 in the TM5, forming an orthosteric binding pocket of higher polarity than the other three sequences with alanine at this position. The other 5-HT receptor types show the presence of non-polar residue alanine in residue 5.42. In invertebrate 5-HT2 receptors a pattern of alanine/threonine is observed, while 5-HT7 receptors interestingly show an alanine/alanine pattern, with only non-polar residues. Very close to these positions, the presence of threonine at position 5.39, a residue in the extended binding site related to ligand selectivity of serotonergic receptor types in humans (21), seems to be a feature of receptors belonging to the 5-HT1 type. Interestingly, in the 5-HT7 receptors cloned by us and others, this position has been replaced with a glutamine residue (Table 1).

Differences were also observed between sequences of the cloned cestode GPCRs and previously characterized invertebrate-vertebrate GPCRs. For example, the DRY motif, which is involved in GPCR activation and almost invariably conserved in the vast majority of GPCRs including other invertebrate sequences [44], was replaced by the sequence ERC or ERA in the three cloned cestode sequences but not in the predicted Eca-5-HT1b (Fig 1B and Table 1). In the PIF motif (5.50, 3.40 and 6.44) that is involved in receptor activation [21], the isoleucine (I 3.40) is replaced by a threonine residue in all three cloned cestode sequences (Table 1). In the sixth transmembrane region, of the two phenylalanines usually seen at positions 6.51 and 6.52, involved in ligand binding and likely also in receptor activation (44), 6.52 was replaced by asparagine in the three sequences reported here and by serine in the hypothetical Eca-5-HT1b.

Previous work has investigated the structural basis of the interaction between the Hsa-5-HT1b receptor and Gαi/o [22]. We therefore analyzed residues in flatworm GPCRs that are potentially involved in Gαi/o coupling (Table 2 and Fig 1B).

Table 2. Residues potentially involved in receptor and G-protein coupling.

  TM 5 TM 7
Hsa-5-HT1b I5.61 A5.65 R5.68 I5.69 S7.57 N7.58
Eca-5-HT1a I A H I S K
Mvo-5-HT1a I A H I S K
Hmi-5-HT1a I A H I S K
Eca-5-HT1b I A R I S P
Dja-5-HT1a I A R I S P
Dja-5-HT1c I I Q T S T
Sma-5-HT1 I A R I S P
Dja-5-HT2b T I Q T N P
Dja-5-HT2c T I Q T N P
Eca-5-HT7a I A M A N R
Eca-5-HT7b I A I V N R
Mvo-5-HT7a I A M A N R
Dja-5-HT7a I A M A N R
Dja-5-HT7f I T M V N R
Sma-5-HT7b I A M S D R

Important residues usually present in receptors of the 5-HT1 type but not commonly observed in other receptor clades were marked in bold. Receptors analyzed in this study were shaded in grey. TM indicates the number of transmembrane domain in each receptor.

A non-polar isoleucine residue was present at position 5.69 in almost all of the sequences belonging to the 5-HT1 (with the exception of Dja-5-HT1c in which this residue was threonine) whereas threonine, alanine, valine or serine were more frequent in other invertebrate clades. The serine at position 7.57 was only seen in 5-HT1 type receptors, whereas it is replaced by asparagine in almost all GPCRs from the 5-HT2 and 5-HT7 types.

Since the four receptors reported in this work were predicted to belong to the 5-HT1 type, it is expected that these GPCRs couple with the Gαi/o family of G proteins. To predict the coupling specificity of the three serotonergic receptors sequenced, the program PRED-COUPLE 2.00 was used (Table 3). The four cestode receptors have high scores for Gαi/o coupling partners, with normalized scores of 0.52 for Eca-5-HT1a, 0.98 for Eca-5-HT1b, 0.44 for Mvo-5-HT1a and 0.60 for Hmi-5-HT1a. However, for the Hmi-5-HT1a, a higher normalized score of 0.93 for the Gαq/11 coupling partner was observed, suggesting that this receptor could have some degree of promiscuity at the type of G protein interaction, increasing the possibility of interaction with both types of G proteins: Gαq/11 and Gαi/o. Therefore, the results shown here seems to arrive to similar conclusions obtained by phylogenetic analyses.

Table 3. Prediction of coupling specificity for the 5-HT1 type of cestode receptors.

G-Protein coupled receptor (GPCR) Gα-protein coupling specificity—normalized score (PRED-COUPLE 2.00)
Eca-5-HT1a i/o0.52
s - 0.27
q/11 - 0.02
12/13 - 0.00
Mvo-5-HT1a i/o0.44
s - 0.17
q/11 - 0.08
12/13 - 0.00
Hmi-5-HT1a q/110.93
i/o0.60
s - 0.00
12/13 - 0.00
Eca-5-HT1b i/o0.98
q/11−0.01
s—0.00
12/13−0.00

Scores were obtained with the program PRED-COUPLE 2.0 which reflects the probability of coupling (from 0, no coupling; to 1, coupling) of the three receptors sequenced in this work with each type of G protein. The best scores according to the program were marked in bold.

Next, homology modeling was performed to determine important structural features of the three cloned GPCRs. For these receptors, Ramachadran plots of the modeled proteins showed that 95.7% or more of all residues were in favored regions, while 99.3% or more residues were in allowed regions and only 0.7% or less residues were in outlier regions of the Ramachandran plots (Fig A–H in S2 Text). In addition, these structure homology models obtained showed ERRAT values higher than 92.9263 and QMEN values close to -4.0, indicating a good quality of the homology structure models. All models showed RMSD values lower than 0.73 Å and TM-align values higher than 0.92725, suggesting that the cestode 5-HT1 receptors studied in this work have a similar structure as Hsa-5-HT1b and a good superposition between these proteins (Table 1 in S2 Text). Homology modeling of the three cestode sequences in this work compared with the human 5-HT1b receptor (Fig 2), revealed high structural similarity at positions and orientations of critical residues like 3.32; 3.37; 5.42 and 5.46 which form part of the orthosteric binding pocket in 5-HT1 receptors (Fig 2B–2E).

Fig 2. Structural comparative analysis of cestode 5-HT1 type serotonergic receptors.

Fig 2

(A-E) Structural similarities and differences among the 5-HT1 type serotonergic receptors of Homo sapiens (Hsa-5-HT1b) and cestodes. (A) Superposition of crystallized Hsa-5-HT1b (orange; PDB 4IAR) and the homology models of Eca-5-HT1a (blue; Echinococcus canadensis G7), Mvo-5-HT1a (green; Mesocestoides vogae), and Hmi-5-HT1a (red; Hymenolepis microstoma). (B-E) Close-up views of the residues involved in the putative ergotamine interaction site of (B) Hsa-5-HT1b, (C) Eca-5-HT1a, (D), Mvo-5-HT1a, and (E) Hmi-5-HT1a, in the transmembrane domains III (labeled III) and V (labeled V). (F-Q) Comparative analysis of residues involved in the ligand binding and G protein coupling sites between cestode 5-HT1 and 5-HT7 type serotonergic receptors. (F, G, J, K, N and O) Close-up views of residues involved in the ligand binding site of (F) Eca-5-HT1a, (G) Eca-5-HT7a, (J), Mvo-5-HT1a, (K), Mvo-5-HT7a, (N), Hmi-5-HT1a, and (O) Hmi-5-HT7a, in the transmembrane domains III (labeled III) and V (labeled V). Note that threonines at positions 3.40 and 5.39 and serine at 5.42 (in bold) in 5-HT1a receptors are replaced by isoleucine, glutamine, and alanine (in red); respectively, in 5-HT7a receptors. (H, I, L, M, P and Q) Close-up views of residues involved in the G protein coupling site of (H) Eca-5-HT1a, (I) Eca-5-HT7a, (L), Mvo-5-HT1a, (M), Mvo-5-HT7a, (P), Hmi-5-HT1a, and (Q) Hmi-5-HT7a, in the transmembrane domains V (labeled V) and VII (labeled VII). Note that histidine, isoleucine, serine, and lysine at the positions 5.68, 5.69, 7.57, and 7.58 (in bold); respectively, in 5-HT1a receptors are replaced by methionine, alanine, asparagines, and arginine residues (in red); respectively, in 5-HT7a receptors. In all the plots, protein structures were represented as cartoons and the residue side chains involved in the putative ergotamine interaction, ligand binding, and G protein coupling sites were represented as sticks.

Additional homology modeling compared the structure of the cloned cestode 5-HT1 GPCRs with 5-HT7 receptors previously reported from cestodes [10], (Fig 2F–2Q and Table 1 in S2 Text). Comparative analysis of the residues involved in receptor binding and G protein coupling showed that both types of receptors (5-HT1 vs 5-HT7) have important structural differences (Fig 2). Critical residues implicated as 5-HT1 type specific (shown in Table 1), for example at positions 5.39 (threonine 5-HT1, glutamine 5-HT7) and 5.42 (polar serine in 5-HT1, nonpolar alanine in 5-HT7) are indeed located in the orthosteric binding pocket of the cestode GPCRs (Fig 2F, 2G, 2J, 2K, 2N & 2O). The tridimensional structure in the 5-HT1 type suggests that the threonine (5.39) is very close to the critical polar serine residue at position 5.42 and points to a higher polarity of the 5-HT1 binding pocket with respect to 5-HT7. Regarding the putative G protein coupling residues, the models reveal that TM5 residues (isoleucine 5.61, alanine 5.65, isoleucine 5.69 and histidine 5.68) and TM7 residues (serine 7.57 and lysine 7.58) are located in positions likely accessible to the G protein from the cytoplasmic side. The coupling residues differ depending of the GPCR type as shown in Table 2. The isoleucine at position 5.69 in 5-HT1 type is replaced by the shorter alanine in the Eca-5-HT7a or valine in Eca-5-HT7b receptors respectively. The hydroxyl group of serine at position 7.57 in 5-HT1 is replaced by the bulkier amide group from asparagine in almost all of the 5-HT7 receptors analyzed (Fig 2H, 2I, 2L, 2M, 2P & 2Q). The inclusion of the nitrogen atom here could be a selectivity determinant for the interaction with the alpha subunit of the G-protein at this position.

One important structural characteristic of 5-HT1 receptors is the presence of a long intracellular loop 3 and the small carboxy terminal end (S4A Fig). By contrast, serotonergic receptors from the clade 7 are characterized by smaller third intracellular loop 3 and bigger carboxy terminal end (S4B Fig). Similar findings are obtained when the human 5-HT1 and 5-HT7 are compared between them (S4C versus S4D Fig).

Functional characterization of Eca-5-HT1a

The cDNA encoding Eca-5-HT1a was transiently transfected into the stable HEK293-GNA15 cell line. In this line, the gene GNA15 encodes the promiscuous Gα15 protein that binds to GPCRs irrespective of their native coupling type and activates calcium release through the Gαq pathway [45]. The dataset here obtained shows that the addition of serotonin to cells transfected with cDNA for Eca-5-HT1a induced calcium release from intracellular stores in a concentration dependent manner (Fig 3A).

Fig 3. Heterologous expression of Eca-5-HT1a receptor.

Fig 3

A) Time resolved measurements of Ca2+ accumulation (measured as raw fluorescence units, RFU) in cells expressing the cestode Eca-5-HT1a before and after addition of different concentrations of 5-HT (arrow, concentrations indicated in legend in μM). B) Concentration-response curve measuring peak amplitude of 5-HT evoked fluorescence change (measured as a percentage) in cells expressing Eca-5-HT1a (green closed squares), or untransfected HEK293-GNA15 cell line (open circles). C) Bar graph showing normalized peak responses in cells transfected with the new receptor to indicated neurotransmitters (10 μM). D) Concentration-response curve measuring 5-HT evoked fluorescence change (measured as raw fluorescence units, RFU) in cells expressing wild type Eca-5-HT1a (red solid dot), or the following mutants: D118A3.32 (blue triangle), C122A3.36 (green inverted triangle), T123A3.37 (purple rhombus) and W542A6.48 (brown triangle). Black solid squares represent the untransfected control (HEK293-GNA15 cell line). E) molecular model of the orthosteric binding pocket in Eca-5-HT1a, showing the role of the mutated residues in serotonin binding. The molecule shown in yellow represent 5-HT. The gray sticks represent the R groups from the amino acids mutated here. In all cases, the amine groups are shown in blue, thiol group is shown in yellow and hydroxyl groups in red. Hypothetical interactions between the 5-HT molecule and receptor mutated residues were marked by dotted lines. Abbreviations are: 5-HT, serotonin; Tyra, tyramine; Octo, octopamine; Ach, acetylcholine; His, histidine; Dopa, dopamine. For panels A) and B), each point represents the average of three biological experiments with three technical replicates each. For panel C), each point represents the average of two biological experiments with three technical replicates each. Error bars corresponds to the standard error of the mean.

The EC50 for serotonin was 7.74 ± 0.63 nM, which shows that the receptor has a high affinity for serotonin. This response was not seen when the cell line was not transfected (Fig 3B). In order to determine if the observed response was specific for serotonin, the transfected GNA15-cells were exposed to other ligands at the same concentration than serotonin (10 μM). The results clearly showed that Eca-5-HT1a responded to serotonin and also, but to a lesser degree, to tryptamine but not to other ligands (biogenic amines or neurotransmitters) confirming the predictions suggested by bioinformatic analysis (Fig 3C).

As it was showed previously in other species, especially in humans, residues located at positions 3.32, 3.36, 3.37 and 6.48 besides others, are playing central roles in receptor binding and function [21]. In order to see if these residues could play also essential roles in cestode receptor function, three residues belonging to the putative ligand binding pocket and one residue conforming the molecular toggle switch, were mutated to alanine in Eca-5-HT1a. As it can be seen in the Fig 3D, the four mutants shown severe impact in receptor function. It was observed that mutants with substitutions at positions 3.32 and 6.48 resulted in complete lack of activity. Substitutions at positions 3.36 and 3.37 resulted in a severe impaired (but mensurable) activity in both mutants, with EC50s of 14.6 and 11.5 μM respectively. The Fig 3E shows the molecular model of the orthosteric binding site in the Eca-5-HT1a receptor. The localization of the mutated residues in the serotonin binding site suggest major roles for such residues in ligand binding and receptor function.

Pharmacological characterization of Eca-5-HT1a

In order to pharmacologically characterize Eca-5-HT1a, we used HEK293 cells stably expressing the promiscuous Gα15 subunit and the Eca-5-HT1a receptor (HEK293-GNA15-Eca-5-HT1a stable cell line). No 5-HT evoked signal was observed in non-transfected cells (HEK293-GNA15 stable cells, results not shown). Agonist responses were obtained when cells expressing Eca-5-HT1a were incubated with increasing 5-HT or the 5-HT receptor agonists α-methylserotonin and 5-methoxytryptamine (Fig 4A). The concentration-response relationship for 5-HT and these agonists was examined at concentrations ranging from 10 pM to 100 μM (Fig 4A). The resulting sigmoidal concentration-response curve of 5-HT shows receptor activation in a concentration-dependent and saturable manner. Half-maximal activation (EC50) was achieved at 5-HT concentrations of 0.002 ± 0.001 μM. The response to 5-HT was followed by 5-methoxytryptamine (EC50 = 0.098 ± 0.05 μM) and finally, by α-methylserotonin (EC50 = 2.73 ± 0.73 μM). By the contrary, methysergide, a non-selective ligand of mammalian serotonin receptors exhibited a concentration-dependent curve of inhibition (Fig 4B).

Fig 4. Effect of various agonists and antagonist on Eca-5-HT1a in HEK293-GNA15 cells.

Fig 4

(A) Concentration-dependent activation of Eca-5-HT1a with 5-HT (black box) or the 5-HT receptor agonists α-methylserotonin (α-MTS, red ball) and 5-methoxytryptamine (5-MTT, blue triangle), shown as the percentage of activation achieved with 5-HT (maximum response = 100%). (B) Concentration-dependent inhibition of Eca-5-HT1a obtained with methysergide on 5-HT (0.03 μM), α-methylserotonin (10 μM) and 5-methoxytryptamine (1 μM) mediated activation. In all cases, data represent the mean of three independent measurements (each performed in triplicate).

Eca-5-HT1a receptor showed a strong pattern of staining typical of the nervous system and suggests a major role in the neuronal function

Whole mount immunofluorescence assays in protoscoleces of E. canadensis, using an antibody against Eca-5-HT1a, revealed a pattern typical of the nervous system with two important masses of stained nerves forming the bilobed brain in the scolex region from which two longitudinal nerve cords projected from the anterior to the posterior end (Fig 5B and 5D).

Fig 5. Inmunolocalization of Eca-5-HT1a in protoscoleces of Echinococcus canadensis.

Fig 5

Protoscoleces were probed with anti-Eca-5-HT1a antibody (red) and anti-tropomyosin antibody or anti-serotonin antibody (green) and visualized by confocal microscopy. A) Phase contrast view of the protoscolex shown in B. B) Fluorescent image of the same protoscolex co-labelled with anti-Eca-5-HT1a antibody and anti-tropomyosin antibody. No evidence of proximity between the two signals were found. Intense signal was found in the cerebral ganglia (cg) and the main longitudinal nerve cords (lnc). C) Phase contrast view of the protoscolex shown in D. D) Fluorescent image of protoscolex co-labelled with anti-Eca-5-HT1a antibody and anti-tropomyosin antibody. The intense green signal shows the complex pattern of muscle fibers (mf). The strong red signal was observed in the cerebral ganglia (cg), the longitudinal nerve cord (lnc) and transverse commissure (tc). E) Phase contrast of the protoscolex shown in F. F) Fluorescent image of protoscolex labelled with preimmune serum obtained from the same mice which were later inoculated with Eca-5-HT1a. G) Phase contrast view of the protoscolex shown in H. H) Fluorescent image of the same protoscolex labelled with anti-Eca-5-HT1a antibody (red). Strong Eca-5-HT1a signal was found in the cerebral ganglia (cg) and the main longitudinal nerve cords (lnc). Some weak signal (arrowheads) could be seen in the surface region of the scolex. I) and J) Two different stack integrations and picture magnifications of the fluorescent image of the protoscolex shown in H. Alternating regions of receptor and serotonin immunoreactivity can be seen (arrowheads) in the scolex region. K) Phase contrast of the protoscolex shown in L. L) Fluorescent image of protoscolex incubated without primary antibody. M) Phase contrast view of the protoscolex shown in N. N) Fluorescent image of the same protoscolex co-labelled with anti-Eca-5-HT1a antibody and anti-serotonin antibody. Strong signal was observed in the cerebral ganglia (cg), the lateral nerve cord (lnc) and the cerebral commissure (co). For the phase contrast images, the tegument (te), body (bo), scolex region (sc) with sucker (su) and the rostellum (ro) were marked. Scale bar 20 μm.

In some pictures, nerve commissures were seen connecting the two longitudinal nerve cords (Fig 5D) and the two lobes of the brain (Fig 5H). When this pattern is compared to the pattern of staining with an anti-tropomyosin antibody (a muscle stain) [44], it can be clearly observed that Eca-5-HT1a does not colocalize with the muscular system (Fig 5B and 5D).

With the aim to elucidate the relationship between this receptor and the neurotransmitter serotonin, colocalization studies were performed using mouse antibodies against the cestode GPCR marked with rhodamine (red) and rabbit antibodies against serotonin marked with FITC (green). The pictures suggest that there is not complete colocalization between serotonin and Eca-5-HT1a signals (Fig 5I, 5J and 5N). In the scolex region, the receptor seems to be in nervous fibers that are contiguous and intertwined but not exactly coincident with the fibers obtained with the anti-serotonin antibody (Fig 5I and 5J). Some pictures also show faint receptor signals in the surface of the scolex region of the worm (Fig 5H). In the body region, some points of contact can be seen between green (serotonergic) and receptor (red) fibers but the overall impression is that there are less contiguous regions than in the scolex (Fig 5N). Cell bodies in the major ganglia clearly stained with serotonin antibodies (i.e. lateral, posterior lateral or rostellar ganglia) were not stained with the anti-receptor antibody (Fig 5N). The pattern of staining suggests that receptor-containing fibers could receive serotonergic input from proximal contiguous fibers.

Discussion

This work reports the initial molecular and functional characterization of a new serotonergic receptor in platyhelminths that likely belongs to the 5-HT1 type of GPCRs. To the best of our knowledge, this is the first functional characterization of a presumptive 5-HT1 type receptor in platyhelminths. Highly conserved orthologues are found in a wide variety of species of cestodes suggesting these receptors could play major roles in the biology of these parasites. The evidence for the presumptive assignment the proteins as a 5-HT1 type of receptors are: 1) phylogenetic analysis, 2) presence of residues in the ligand-binding pocket that are characteristic of 5-HT1 type, 3) presence of putative G-protein coupling residues (selectivity determinants of the receptor) that are more similar to the 5-HT1 type than to other clades, and finally, 4) structural features typical of 5-HT1 type of receptors.

5-HT1 type GPCRs is expected to be coupled to the Gαi/o family of G proteins to cause inhibition of cAMP dependent signaling. This represents the opposite outcome to the rise of cAMP after the activation of 5-HT7 type of cestode receptors which were recently deorphanized [10]. Relatively few helminth GPCRs have been deorphanized to date, and further efforts are needed to characterize how they operate and their in vivo roles.

In spite of the overall similarity of the novel cestode receptors to the 5-HT1 type receptors, some uniqueness in residues and motifs critical for receptor function were identified: first, the receptor has an ERC or ERA motif after the third transmembrane domain but not the classical DRY domain. Second, the PIF domain is replaced by a PTF domain. Third, phenylalanine at position 6.52, which is an essential component of a cluster of aromatic residues that surrounds tryptophan 6.48, referred as a “receptor toggle switch”, is replaced by asparagine [46]. The substituted residues form part of conserved motifs well known as “molecular microswitches” or highly conserved motifs related to the stabilization of GPCRs in activated or inactivated states [44, 47]. The significance of these substitutions is unclear but could be of importance as they suggest potential differences in the mechanisms of receptor activation/inactivation under ligand binding or pharmacology with the human counterparts. These motifs are not only different with other invertebrate 5-HT1 members but also with the mammalian Hsa-5-HT1b. Possibly, these differences could be exploited for selective druggability. The hypothetical Eca-5-HT1b seems to be more conserved at these canonical motifs, however, the substitution of alanine by serine at the key position 5.46, could result in relevant differences in pharmacological profiles with other orthologous receptors from other species.

The heterologous expression studies of the E. canadensis receptor confirm that the molecule is functional, responding specifically to the addition of 5-HT in a concentration-dependent and high affinity manner. Tryptamine, a well-known agonist of 5-HT GPCRs [48], also elicited a strong response in the presence of the cestode receptor but to a lesser degree than to 5-HT. Other invertebrate 5-HT1 receptors, for example Trica5-HT1 receptor from the red flour beetle, Tribolium castaneum [49], was shown to be insensitive to tryptamine and this could suggest that the cestode receptor could be less selective to other biogenic amines than the insect receptor. The synthetic agonists 5-methoxytryptamine and α-methylserotonin give good responses and both were tested in the previously mentioned Trica5-HT1 with similar responses [49]. However, the sensitivity to 5-methoxytryptamine was higher than to α-methylserotonin and this difference in agonist activity could be explained probably by the lower tolerance to replacements near the primary amine of 5-HT (which seems to make contacts with the aspartate 3.32 and cysteine 3.36 of Eca-5-HT1a) than in the proximity of the hydroxyl group. The well-known 5-HT GPCR ligand methysergide, has been described as having agonist and antagonist activities in invertebrates [13]. In this work, good blocking activity was observed with this ligand in Eca-5-HT1a. Mutagenesis studies confirms major roles for residues at positions 3.32, 3.36, 3.37 and 6.48, indicating that they could be part of the binding pocket and/or receptor activation mechanism also in cestodes. In mammals, it was postulated that aspartate in position 3.32 is forming a salt bridge with the positively charged amino group of 5-HT [21]. This interaction could be seriously affected when aspartate is replaced by alanine, interfering with ligand binding. Another important residue analyzed was threonine 3.37, which was postulated to form a hydrogen bond with the indole N-H [21]. This type of interaction could be abolished when the polar threonine is replaced by the non-polar alanine in the cestode mutant receptor. However, some activity could be detected using this latter mutant suggesting that this residue is very important but not critical for receptor function. Tryptophan 6.48 is an essential component of aromatic residues referred to as a “toggle switch”, which includes phenylalanine 6.44, phenylalanine 6.51 and phenylalanine 6.52 [46]. It is thought that the movement of the tryptophan 6.48 is one of the major features of receptor activation [46]. The results obtained here shown a complete lack of activity after the substitution of tryptophan by alanine at the residue 6.48 suggesting that this replacement could interfere with this mechanism of receptor activation also in cestodes. For residue 3.36, it was postulated that it could stabilize tryptophan 6.48 by Van der Waals interactions. It was postulated that one potential role for residue 3.36 is to stabilize the conformation of the receptor in an inactive state. The replacement of cysteine by alanine could abolish this interaction resulting in a very low activity in the cestode mutant. In summary, bioinformatic analyses predicts residues with major function in Cestode receptors and some of this residues were confirmed to be of paramount importance in receptor function by mutant analyses.

The confocal microscopy performed in protoscoleces of E. canadensis revealed a pattern of staining consistent with expression in the central and peripheral nervous system. Some nervous fibers and ganglia were revealed with the antibody against the Eca-5-HT1a receptor but co-localization with an anti-serotonin antibody suggests that serotonin fibers were not the same as those stained with the anti-Eca-5-HT1a antibody. In the images shown, both types of fibers seem to be intertwined like a mesh suggesting that the serotonergic fibers are close enough to release serotonin that could be received by the fibers expressing the GPCR. However, comparisons between receptor and serotonin locations should be interpreted with caution since quiet a lot serotonin background staining could be seen, especially in the tegument of the worm. In the light of the deep knowledge of serotonin neuroanatomy in Echinococcus spp. [14, 41, 50, 51], high levels of serotonergic staining observed in the tegument seems to be an artifact probably due to the low titers and high concentrations of the serotonin antibody used. Anyways, the fluorescence images obtained with the anti-Eca-5-HT1a antibody showed the classical orthogonal pattern with two bilobed structures resembling the brain and two longitudinal cords emerging from this primitive brain. Minor Eca-5-HT1a staining at the tegument surface could also be observed, which suggests the existence of potential sensitive nerve endings [52]. The participation of the receptor in the neuromuscular plaque is not clear: in some pictures some fibers emanated from the central nervous system toward the more superficial muscular system but the images are not conclusive in this way. Similar results of nervous system staining were obtained by Patocka and colleagues [16] for Sm-5-HTR: a 5-HT7 type of GPCR from S. mansoni. Using a purified antibody against this receptor the authors also found strong immunoreactive nerve fibers in schistosomulae and adults. An important difference between Eca-5-HT1a and Sm-5-HTR was that, in the case of cestode receptor, no expression could be seen outside from the nervous system whereas Sm-5-HTR was expressed in the digestive system of S. mansoni worms. While classical neurotransmitters such as GABA and glutamate appear to function mainly locally at synapses, serotonin can act locally but also in a paracrine way, diffusing several microns from its release sites at concentrations sufficient to activate its receptors [53]. Furthermore, serotonin receptors are often localized at nonsynaptic sites [54]. These observations suggest that serotonin might act as an extrasynaptic signal to activate several receptor types on cells distant from its release [53]. In C. elegans, one of the several behaviors controlled by serotonin is enhanced slowing which is characterized by significant lower levels of worm motility after serotonin addition. This response was found to be mediated by SER-4 (Cel-5-HT1) receptor [55]. Interestingly, it was found here that ser-4, represented in the phylogenetic three as Cel-5-HT1a grouped in the same clade than Eca-5-HT1a.

In parasitic nematodes, a piperazine derivative and known 5-HT1 agonist was proposed as a potential anthelmintic agent [20]. The evidence presented suggests that compounds with affinity for this type of GPCR could be used as an antiparasitic. On the other hand, the transcriptomic data of the present study suggest a restricted expression to the protoscolex stage. The high expression levels of receptor transcripts in the protoscolex stage is coincident with the strong immunofluorescent signal detected in the same stage. The restricted expression in the larval protoscolex stage is interesting because this receptor could be used in the future as a reliable marker of cyst fertility. In a previous study [56], different transcriptional levels of the serotonergic GPCR Emu-5-HT7a (hypothetical ortologue of Eca-5-HT7a [10] and described as the gene model EmuJ_001171200 in the publication) was reported between different stages in E. multilocularis suggesting a role of this type of receptors in parasite development. In a recent report [57], it was found that serotonin has profound effects in E. multilocularis development. It could be interesting to hypothesize if some or all of the developmental effects observed on this last report could be mediated by the serotonergic activation of a putative Emu-5-HT1a (the prescence of an hypothetical E. multilocularis version of the receptor deorphanized here) and/or the activation of Emu-5-HT7a and/or Emu-5-HT7b (the presence of hypothetical E. multilocularis versions of the cestode receptors already described in our previous report [10]).

The putative 5-HT1 cestode receptors are probably evolutionary distant orthologues of the human Hsa-5-HT1b receptor. In H. sapiens, this latter receptor couples to G protein alpha subunits Gαi or Gαo and is widely expressed in the brain and the cardiovascular system. In the CNS, the Hsa-5-HT1b receptor functions as an inhibitory presynaptic receptor to modulate the release of 5-HT and many other neurotransmitters [58, 59]. The Hsa-5-HT1b receptor is a primary molecular target for the antimigraine drugs ergotamine and dihydroergotamine, which are efficacious Hsa-5-HT1b receptor agonists. The possibility of repurposing any of the approved drugs for human treatment of parasitic diseases should be evaluated.

In summary, the results of this work suggest that the newly discovered cestode receptor belongs to the 5-HT1 type, is functional responding specifically to serotonin but not to other ligands and could have a major role in the nervous system of these parasites. We believe that this novel type of receptors could be an amenable target for a new generation of cestocidal drugs.

Supporting information

S1 Fig. Antigen analysis by western blot and antibody titer evaluation by ELISA.

A) Lane 1, GenScript protein marker (Cat. No. M00521); lane 2, 5 μg of Eca-5-HT1aICL3. The antigen was run in polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane. The membrane was probed with antibody against poly-histidine tag. The arrow shows the position of the band detected. B) The recombinant antigen produced was administered in six mice and then anti-Eca-5-HT1aICL3 antibody titers were evaluated by ELISA technique. End-point titer was calculated as the reciprocal of the dilution with an Absorbance 450 nm = 0.5. The antibody titers are indicated in the table from the right. “Pre” represents the specific antibody titer of pre-immunized mice.

(TIF)

S2 Fig. Transcriptional expression levels of serotonergic GPCRs genes in Echinococcus granulosus.

Egr-5-HT1a, Egr-5-HT1b, Egr-5-HT7a and Egr-5-HT7b GPCRs transcriptional expression levels are shown as RPKM (Reads Per Kilobase Million). Comparison of gene expression levels, determined by RNAseq, in several developmental stages of Echinococcus granulosus sensu stricto (G1): Oncosphere, Cyst, Protoscolex and Adult [26]. The closest orthologue of the receptor studied here, Egr-5-HT1a, was marked in bold and the level of transcript expression of this receptor in the protoscolex stage was marked with an arrow. With exception of the protoscolex larval stage, no transcript expression was observed for this receptor in other stages of the parasite.

(TIF)

S3 Fig. Bioinformatic analyses of the hypothetical Eca-5-HT1b receptor.

A. The bidimensional structure representation and prediction of residues of potential N-glycosylation of Eca-5-HT1b were obtained with the Protter program (http://www.enzim.hu/hmmtop/index.php). The intracellular and extracellular loops are indicated as ICL and ECL respectively. The third intracellular loop used for antibody generation is shaded in grey. Residues potentially involved in N-linked glycosylation were marked in green. B. The amino acid sequences of predicted serotonin receptors ortologues with best scores in blast searches with the cestode Eca-5-HT1b were aligned using the ClustalW method. The new 5-HT1 type cloned receptors’ names are marked in bold. The transmembrane (TM), intracellular (ICL) and extracellular (ECL) domains are indicated above each alignment. For the sake of simplicity, the amino terminal end, the transmembrane domain 1, the intracellular loop three and the carboxy terminal end were trimmed partially or completely. The position of residues involved in G protein coupling are indicated with asterisks below each alignment. Residues present in the new predicted receptors that were not seen in other GPCRs are underlined. Critical residues involved in ligand binding and receptor function were indicated in bold below each alignment. Cysteine residues potentially involved in disulphide bond formation are marked as S-S between cysteines. The receptor names, identification numbers and the corresponding species from which the receptors were obtained are enlisted in Table C from S1 Text.

(TIF)

S4 Fig. Structural comparative analysis between serotonergic type 1 and type 7 receptors.

Comparative analysis of the general structures of the homology models to 5-HT1- vs 5-HT7-type serotonergic receptors from Echinococcus canadensis G7 (A) Eca-5-HT1a and (B) Eca-5-HT7a; and Homo sapiens (C) Hsa-5-HT1a and (D) Hsa-5-HT7a. In all the representations, the transmembrane domains I to VII (7-TM) were represented as cartoon while the intracellular loop 3 (ICL3) and C-terminus regions (C-term) were represented as surface. Note the smaller ICL3 and longer carboxy terminal end in 5-HT7-type receptors with respect to 5-HT1-type receptors, in which a bigger ICL3 and smaller C-term (marked as a short cartoon) can be seen.

(TIF)

S1 Table. G-protein coupling selectivity score for experimentally validated invertebrate 5-HT GPCRs.

(DOCX)

S1 Data. Excel spreadsheet containing, in separate sheets, the underlying numerical data for Fig 3A–3D, Fig 4A and 4B, and S1 Fig.

(XLSX)

S1 Raw image. Original image from the western blot provided by Genscript in the certificate of analysis of recombinant Eca-5-HT1aICL3.

(TIF)

S1 Text. Nucleotide and translated amino acid sequences of the third loop of Eca-5-HT1a.

(DOCX)

S2 Text. Parameters and Ramachandran plots for the structure models generated in this work.

(DOCX)

Acknowledgments

We would like to thanks to Eduardo Gimenez for his technical assistance in the lab. We especially thanks to Doctors Andrés Rossi from the Leloir Institute and Pablo Pomata from the IBYME institute for their special technical skills with the confocal microscope.

Data Availability

All the accession numbers are available from the Genbank database (accession number(s) MW535743 for Eca-5HT1a; MW535744 for Mvo-5HT1a and MW535745 for Hmi-5HT1a).

Funding Statement

This work was supported by Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina and by Secretaria de Ciencia y Técnica (UBACyT), Universidad de Buenos Aires, Facultad de Medicina, Argentina. Project Programación Científica 2016, code 20020150100160BA, PICT 2017 N°2966. HRV is a recipient of a CONICET postdoctoral fellowship. JSM and SKP were supported by the NIH (R01 AI145871). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Vuitton DA, McManus DP, Rogan MT, Romig T, Gottstein B, Naidich A, et al. International consensus on terminology to be used in the field of echinococcoses. Parasite. 2020;27:41. doi: 10.1051/parasite/2020024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.World Health Organization. Accelerating work to overcome the global impact of neglected tropical diseases: a roadmap for implementation: executive summary. 2012. World Health Organization. https://apps.who.int/iris/handle/10665/70809 [Google Scholar]
  • 3.Lindquist HDA & Cross JH. Chapter 195—Helminths, Editor(s): Cohen Jonathan, Powderly William G., Opal Steven M., Infectious Diseases (Fourth Edition), Elsevier, 2017, Pages 1763–1779.e1. doi: [DOI] [Google Scholar]
  • 4.Cunningham LJ, Olson PD. Description of Hymenolepis microstoma (Nottingham strain): a classical tapeworm model for research in the genomic era. Parasit Vectors. 2010. Dec 31;3:123. doi: 10.1186/1756-3305-3-123 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Tsai IJ, Zarowiecki M, Holroyd N, et al. The genomes of four tapeworm species reveal adaptations to parasitism. Nature. 2013;496(7443):57‐63. doi: 10.1038/nature12031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Markoski MM, Bizarro CV, Farias S, et al. In vitro segmentation induction of Mesocestoides corti (Cestoda) tetrathyridia. J Parasitol. 2003;89(1):27–34. doi: 10.1645/0022-3395(2003)089[0027:IVSIOM]2.0.CO;2 [DOI] [PubMed] [Google Scholar]
  • 7.Development Hemphill A. and applications of cestode and trematode laboratory models. Parasitology. 2010;137(3):329–333. doi: 10.1017/S0031182010000132 [DOI] [PubMed] [Google Scholar]
  • 8.Conn DB. The rarity of asexual reproduction among Mesocestoides tetrathyridia (Cestoda). J Parasitol. 1990;76(3):453–455. doi: 10.2307/3282690 [DOI] [PubMed] [Google Scholar]
  • 9.Hrckova G, Velenbný S, Halton DW, Maule AG. Mesocestoides corti (syn. M. vogae): modulation of larval motility by neuropeptides, serotonin and acetylcholine. Parasitology. 2002;124(Pt 4):409–421. doi: 10.1017/s0031182001001329 [DOI] [PubMed] [Google Scholar]
  • 10.Camicia F, Celentano AM, Johns ME, Chan JD, Maldonado L, Vaca H, et al. Unique pharmacological properties of serotoninergic G-protein coupled receptors from cestodes. PLoS Negl Trop Dis. 2018. Feb 9;12(2):e0006267. doi: 10.1371/journal.pntd.0006267 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.McVeigh P, Maule AG, Flatworm Neurobiology in the Postgenomic Era. In Byrne John H., editor. The Oxford Handbook of Invertebrate Neurobiology Oxford University Press, 2019, 40 pages. doi: 10.1093/oxfordhb/9780190456757.013.8 [DOI] [Google Scholar]
  • 12.Chan JD, Cupit PM, Gunaratne GS, McCorvy JD, Yang Y, Stoltz K, et al. The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand. Nat Commun. 2017. Dec 5;8(1):1910. doi: 10.1038/s41467-017-02084-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Tierney AJ. Invertebrate serotonin receptors: a molecular perspective on classification and pharmacology. J Exp Biol. 2018;221(Pt 19):jeb184838. Published 2018 Oct 4. doi: 10.1242/jeb.184838 [DOI] [PubMed] [Google Scholar]
  • 14.Camicia F, Herz M, Prada LC, et al. The nervous and prenervous roles of serotonin in Echinococcus spp. Int J Parasitol. 2013;43(8):647‐659. doi: 10.1016/j.ijpara.2013.03.006 [DOI] [PubMed] [Google Scholar]
  • 15.Chan JD, Agbedanu PN, Grab T, Zamanian M, Dosa PI, Day TA, et al. Ergot Alkaloids (Re)generate New Leads as Antiparasitics. PLoS Negl Trop Dis. 2015. Sep 14;9(9):e0004063. doi: 10.1371/journal.pntd.0004063 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Patocka N, Sharma N, Rashid M, Ribeiro P. Serotonin signaling in Schistosoma mansoni: a serotonin-activated G protein-coupled receptor controls parasite movement. PLoS Pathog. 2014;10(1):e1003878. doi: 10.1371/journal.ppat.1003878 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Chan JD, Day TA, Marchant JS. Coalescing beneficial host and deleterious antiparasitic actions as an antischistosomal strategy. Elife. 2018;7:e35755. Published 2018 Jul 30. doi: 10.7554/eLife.35755 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Chan JD, McCorvy JD, Acharya S, Johns ME, Day TA, Roth BL, et al. A Miniaturized Screen of a Schistosoma mansoni Serotonergic G Protein-Coupled Receptor Identifies Novel Classes of Parasite-Selective Inhibitors. PLoS Pathog. 2016. May 17;12(5):e1005651. doi: 10.1371/journal.ppat.1005651 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Gürel G, Gustafson MA, Pepper JS, Horvitz HR, Koelle MR. Receptors and other signaling proteins required for serotonin control of locomotion in Caenorhabditis elegans. Genetics. 2012;192(4):1359–1371. doi: 10.1534/genetics.112.142125 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.White WH, Gutierrez JA, Naylor SA, et al. In vitro and in vivo characterization of p-amino-phenethyl-m-trifluoromethylphenyl piperazine (PAPP), a novel serotonergic agonist with anthelmintic activity against Haemonchus contortus, Teladorsagia circumcincta and Trichostrongylus colubriformis. Vet Parasitol. 2007;146(1–2):58–65. doi: 10.1016/j.vetpar.2007.02.014 [DOI] [PubMed] [Google Scholar]
  • 21.Wang C, Jiang Y, Ma J, et al. Structural basis for molecular recognition at serotonin receptors. Science. 2013;340(6132):610‐614. doi: 10.1126/science.1232807 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.García-Nafría J, Nehmé R, Edwards PC, Tate CG. Cryo-EM structure of the serotonin 5-HT1B receptor coupled to heterotrimeric Go. Nature. 2018;558(7711):620‐623. doi: 10.1038/s41586-018-0241-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Baz A, Hernández A, Dematteis S, Carol H, Nieto A. Idiotypic modulation of the antibody response of mice to Echinococcus granulosus antigens. Immunology. 1995;84(3):350–354 [PMC free article] [PubMed] [Google Scholar]
  • 24.Cucher M, Prada L, Mourglia-Ettlin G, et al. Identification of Echinococcus granulosus microRNAs and their expression in different life cycle stages and parasite genotypes. Int J Parasitol. 2011;41(3–4):439–448. doi: 10.1016/j.ijpara.2010.11.010 [DOI] [PubMed] [Google Scholar]
  • 25.Ballesteros JA, Weinstein H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods in neurosciences. 1995; 25:366–428. doi: 10.1016/S1043-9471(05)80049-7 [DOI] [Google Scholar]
  • 26.Felsenstein J. CONFIDENCE LIMITS ON PHYLOGENIES: AN APPROACH USING THE BOOTSTRAP. Evolution. 1985;39(4):783–791. doi: 10.1111/j.1558-5646.1985.tb00420.x [DOI] [PubMed] [Google Scholar]
  • 27.Jones DT, Taylor WR, Thornton JM. The rapid generation of mutation data matrices from protein sequences. Comput Appl Biosci. 1992;8(3):275–282. doi: 10.1093/bioinformatics/8.3.275 [DOI] [PubMed] [Google Scholar]
  • 28.Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms. Mol Biol Evol. 2018;35(6):1547–1549. doi: 10.1093/molbev/msy096 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Rambaut A. (2010) FigTree v1.3.1. Institute of Evolutionary Biology, University of Edinburgh, Edinburgh. http://tree.bio.ed.ac.uk/software/figtree/ [Google Scholar]
  • 30.Sgourakis NG, Bagos PG, Hamodrakas SJ. Prediction of the coupling specificity of GPCRs to four families of G-proteins using hidden Markov models and artificial neural networks. Bioinformatics. 2005;21(22):4101–4106. doi: 10.1093/bioinformatics/bti679 [DOI] [PubMed] [Google Scholar]
  • 31.Sgourakis NG, Bagos PG, Papasaikas PK, Hamodrakas SJ. A method for the prediction of GPCRs coupling specificity to G-proteins using refined profile Hidden Markov Models. BMC Bioinformatics. 2005; 6: 104. Published 2005 Apr 22. doi: 10.1186/1471-2105-6-104 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Zheng H., Zhang W., Zhang L. et al. The genome of the hydatid tapeworm Echinococcus granulosus. Nat Genet 45, 1168–1175 (2013). doi: 10.1038/ng.2757 [DOI] [PubMed] [Google Scholar]
  • 33.Finn RD, Mistry J, Schuster-Böckler B, Griffiths-Jones S, Hollich V, Lassmann T, et al. Pfam: clans, web tools and services. Nucleic Acids Res. 2006;34: D247–D251. doi: 10.1093/nar/gkj149 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJE. The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc. 2015;10: 845–58. doi: 10.1038/nprot.2015.053 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Arnold K, Bordoli L, Kopp J, Schwede T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics. 2006;22: 195–201. doi: 10.1093/bioinformatics/bti770 [DOI] [PubMed] [Google Scholar]
  • 36.Benkert P, Tosatto SCE, Schomburg D. QMEAN: A comprehensive scoring function for model quality assessment. Proteins Struct Funct Bioinforma. 2008;71: 261–277. doi: 10.1002/prot.21715 [DOI] [PubMed] [Google Scholar]
  • 37.Biasini M, Bienert S, Waterhouse A, Arnold K, Studer G, Schmidt T, et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res. 2014;42: W252–W258. doi: 10.1093/nar/gku340 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Colovos C, Yeates TO. Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Sci. 1993;2: 1511–1519. doi: 10.1002/pro.5560020916 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Zhang Y, Skolnick J. TM-align: A protein structure alignment algorithm based on the TM-score. Nucleic Acids Res. 2005;33: 2302–2309. doi: 10.1093/nar/gki524 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.International Helminth Genomes Consortium. Comparative genomics of the major parasitic worms. Nat Genet. 2019. Jan;51(1):163–174. doi: 10.1038/s41588-018-0262-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Koziol U, Krohne G, Brehm K. Anatomy and development of the larval nervous system in Echinococcus multilocularis. Front Zool. 2013;10(1):24. doi: 10.1186/1742-9994-10-24 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Koziol U, Costábile A, Domínguez MF, et al. Developmental expression of high molecular weight tropomyosin isoforms in Mesocestoides corti. Mol Biochem Parasitol. 2011;175(2):181–191. doi: 10.1016/j.molbiopara.2010.11.009 [DOI] [PubMed] [Google Scholar]
  • 43.Maldonado LL, Assis J, Araújo FMG, Salim ACM, Macchiaroli N, Cucher M, et al., 2017. The Echinococcus canadensis (G7) genome: a key knowledge of parasitic platyhelminth human diseases. BMC Genomics 18, 204. doi: 10.1186/s12864-017-3574-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.McCorvy JD, Roth BL. Structure and function of serotonin G protein-coupled receptors. Pharmacol Ther. 2015;150:129–142. doi: 10.1016/j.pharmthera.2015.01.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Kostenis E, Waelbroeck M, Milligan G. Techniques: promiscuous Galpha proteins in basic research and drug discovery. Trends Pharmacol Sci. 2005. Nov;26(11):595–602. doi: 10.1016/j.tips.2005.09.007 [DOI] [PubMed] [Google Scholar]
  • 46.Nichols DE, Nichols CD. Serotonin receptors. Chem Rev. 2008;108(5):1614–1641. doi: 10.1021/cr078224o [DOI] [PubMed] [Google Scholar]
  • 47.Nygaard R, Frimurer TM, Holst B, Rosenkilde MM, Schwartz TW. Ligand binding and micro-switches in 7TM receptor structures. Trends Pharmacol Sci. 2009. May;30(5):249–59. doi: 10.1016/j.tips.2009.02.006 [DOI] [PubMed] [Google Scholar]
  • 48.Hobson RJ, Geng J, Gray AD, Komuniecki RW. SER-7b, a constitutively active Galphas coupled 5-HT7-like receptor expressed in the Caenorhabditis elegans M4 pharyngeal motorneuron. J Neurochem. 2003. Oct;87(1):22–9. doi: 10.1046/j.1471-4159.2003.01967.x [DOI] [PubMed] [Google Scholar]
  • 49.Vleugels R, Lenaerts C, Baumann A, Vanden Broeck J, Verlinden H. Pharmacological characterization of a 5-HT1-type serotonin receptor in the red flour beetle, Tribolium castaneum. PLoS One. 2013. May 31;8(5):e65052. doi: 10.1371/journal.pone.0065052 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Brownlee DJ, Fairweather I, Johnston CF, Rogan MT. Immunocytochemical localization of serotonin (5-HT) in the nervous system of the hydatid organism, Echinococcus granulosus (Cestoda, Cyclophyllidea). Parasitology. 1994. Aug;109 (Pt 2): 233–41. doi: 10.1017/s0031182000076356 [DOI] [PubMed] [Google Scholar]
  • 51.Fairweather I, McMullan MT, Johnston CF, Rogan MT, Hanna RE. Serotoninergic and peptidergic nerve elements in the protoscolex of Echinococcus granulosus (Cestoda, Cyclophyllidea). Parasitol Res. 1994;80(8):649–56. doi: 10.1007/BF00932948 [DOI] [PubMed] [Google Scholar]
  • 52.Ribeiro P. Exploring the role of biogenic amines in schistosome host-parasite interactions. Trends Parasitol. 2015;31(9):404‐405. doi: 10.1016/j.pt.2015.07.003 [DOI] [PubMed] [Google Scholar]
  • 53.Bunin MA, Wightman RM. Quantitative evaluation of 5-hydroxytryptamine (serotonin) neuronal release and uptake: an investigation of extrasynaptic transmission. J Neurosci. 1998;18(13):4854–4860. doi: 10.1523/JNEUROSCI.18-13-04854.1998 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Kia HK, Brisorgueil MJ, Hamon M, Calas A, Vergé D. Ultrastructural localization of 5-hydroxytryptamine1A receptors in the rat brain. J Neurosci Res. 1996;46(6):697–708. doi: [DOI] [PubMed] [Google Scholar]
  • 55.Law W, Wuescher LM, Ortega A, Hapiak VM, Komuniecki PR, Komuniecki R. Heterologous Expression in Remodeled C. elegans: A Platform for Monoaminergic Agonist Identification and Anthelmintic Screening. PLoS Pathog. 2015;11(4):e1004794. Published 2015 Apr 30. doi: 10.1371/journal.ppat.1004794 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Li L, Chen B, Yan H, Zhao Y, Lou Z, Li J, et al. (2018) Three-dimensional hepatocyte culture system for the study of Echinococcus multilocularis larval development. PLoS Negl Trop Dis 12(3): e0006309. doi: 10.1371/journal.pntd.0006309 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Herz M, Brehm K. Serotonin stimulates Echinococcus multilocularis larval development. Parasit Vectors. 2021. Jan 6;14(1):14. doi: 10.1186/s13071-020-04533-0 ; PMCID: PMC7789706 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med. 2009;60:355–366. doi: 10.1146/annurev.med.60.042307.110802 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Hoyer D, Clarke DE, Fozard JR, et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev. 1994;46(2):157–203 [PubMed] [Google Scholar]
PLoS One. 2021 Nov 11;16(11):e0259104. doi: 10.1371/journal.pone.0259104.r001

Author response to previous submission


Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

13 Apr 2021

Attachment

Submitted filename: Response to reviewers 2021 3 31.docx

Decision Letter 0

Wolfgang Blenau

8 May 2021

PONE-D-21-12202

Characterization of a new type of neuronal 5HT G protein coupled receptor in the cestode nervous system

PLOS ONE

Dear Dr. Camicia,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process

After reading the manuscript and the Reviewer's comments for PLOS Neglected Tropical Diseases, I decided to have the manuscript reviewed by an expert in the field of GPCRs of invertebrates (Reviewer #1). The three Reviewers in the first round were all parasitology experts. Since I myself have some experience with characterizing serotonin receptors, I absolutely agree with the criticisms made by Reviewer #1. In order to demonstrate an inhibitory effect on adenylate cyclase, it is essential to first stimulate the enzyme with forskolin or NKH447. A number of potential 5HT receptor antagonists should be tested, not just those that are highly specific for the 5-HT1A subtype in vertebrates. For the selection of the ligands, I strongly recommend a look at the insect literature (Drosophila melanogaster, Apis mellifera, Periplaneta amercicana, Tribolium castaneum ...). For more details, please see the report of Reviewer #1. For your information: Reviewer #2 corresponds to Reviewer #3 of the 1st round).

Please submit your revised manuscript by July 15th, 2021. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Wolfgang Blenau

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In your Methods section, please provide the name of the slaughterhouse where the animals were sacrificed.

3.  We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

4. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.

In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Camicia et al. provide a revised version of their manuscript that I had not evaluated in the first round of the reviewing process. The authors have conducted a molecular and bioinformatics approach and identified potential members of the serotonin (5-HT) 1 clade of G-protein coupled receptors in E. canadensis, M. vogae, and H. microstoma. Classifiction of the receptor proteins is mainly based on bioinformatic evidence. The manuscript in general is valuable and extends current knowledge on the repertoire of biogenic amine receptors expressed in platyhelminthes. The bioinformatics part of study has been conducted with high precision and depth. However, certain aspects especially the pharmacological characterization of the receptors require further experimental investigation to unequivocally support classifying the receptors as 5-HT1 clade members. My general and specifc comments are outlined in the following paragraphs.

General comments

Throughout the manuscript the authors should strictly use the conventional nomenclature used by the ‘serotonin receptor community’: serotonin (= 5-hydroxy tryptamine, 5-HT) and subscript for receptor sub-families: 5-HT1.

Another fail in spelling should be corrected: use G-protein coupled receptors (GPCRs) as well as G-proteins throughout the manuscript.

Substitute ‘dose(s)’ for concentration(s); and use the term ‘concentration-response curve’.

A main issue of concern, however, goes to the pharmacological data provided in the manuscript. It is a common and well-taken approach to study, e.g., a newly cloned receptor gene in a ‘reporter’ cell line. For this purpose the authors have chosen cells that constitutively express a promiscuous G-protein (G15). This is a smart experimental design to gain first insight into a receptor’s functionality. However, the data shown in Fig. 3A and 3B raise certain doubts and are (in part) incorrect:

a) in Fig. 3A the concentration is missing. I guess it is µM(?).

b) scaling of the ordinate is inappropriate (omit negative values; in 3B, too) and has to be changed.

c) exposure/measuring time for cell-based Ca++ fluorescent assays would be extremely long according to the values given on the abscissa (approx. 80 min total measuring time). In the Mat. and Meth. section, the authors state that measurements were performed in scales of seconds. What is correct? I assume, as typical for Ca++ imaging experiments, the latter and, thus, the graph requires editing.

d) The authors state that Fig.3A contains raw data. This does not fit to Mat. and Meth. (l.337ff) and it would be better to display the graphs either as �RFU vs time or as �RFU/R0 (= mean basal fluorescence) vs time.

e) How do the authors explain that fluorescent signals decrease approx. 40 min (sec?) after 5-HT application for almost all ligand concentrations, except for 50µM?

f) Which concentrations (5-HT) were used to calculate the concentration-response curve displayed in Fig.3B? Labeling of the ordinate seems to be wrong (5-HT µM). I guess it is (M), otherwise the deduced EC50 would be six orders of magnitude smaller than given in the manuscript (~7.7 nM). Data points for (0µM) 5-HT are missing! Have they been assigned to 10-11µM 5-HT? This should be changed and the graph adapted accordingly. Furthermore, instead of 100µM (=10-4M) 5-HT, the highest concentration of 5-HT shown in Fig.3A and also stated in Mat. and Meth. was 50µM (=5x10-4M). Therefore, the graph has to be corrected also in this respect.

g) Fig.3C should be exchanged for a bar graph in which the normalized peak values of fluorescence are displayed and, eventually, negative values might be defined as 0. It would have been also more appropriate to use identical ligand concentrations (here 10 µM) in all measurements and the authors should provide these data. Can the authors explain why histamine application causes a fluorescent signal?

h) The experiments performed to examine the potential coupling of the receptor to cAMP signalling suffer from faulty experimental design. Given that the receptor belongs to the 5-HT1 subfamily, the most obvious assumption were, that receptor activation leads to a reduction of the intracellular cAMP concentration. To assess this effect experimentally, cells have to be incubated with (1) IBMX to block PDE activities and (b) with forskoin or its derivative (NKH477) to stimulate endogenous membrane-bound adenylyl cyclases. In this way, one would gain an increase in cAMP. Upon adding a concentration series of 5-HT, the authors should be able to register a reduction of the cAMP concentration – leading to a nice and convincing demonstration of the correct assignment of the receptor. The authors may employ their (cAMP)-reporter cell assay referred to in the manuscript for this purpose or use a commercial kit to determine cAMP concentrations. Without such data, the value of the manuscript is considerably reduced.

i) A final concern addresses the pharmacological profile of the receptor. The authors state that potential agonists did not or only scarcely induce receptor activity. However, the authors should examine and provide data on the effects of antagonists, too. They may select characteristic ones from the rich source of compounds that are known to interact with 5-HT1 receptors in a variety of other species, including insects. It should be rather straightforward to use the Ca++ imaging set-up to perform such experiments.

Specific comments

l.38: ‘…GPCR motifs…’

l.40: as stated above change nomenclature to Eca-5-HT1a

l.88: change to: ‘…5-HT receptors are known but…’

l.90f: skip ‘…determined by similarities in sequence and transduction mechanisms [ ]’

l.92: ‘…system exists based…’

l.92-94: referring to C.elegans assignment of 5-HT clades is more confusing than helpul. Skip sentence.

l.95ff: re-order sentences; starting with 5-HT1 receptors and ending with 5-HT7-like receptors.

l.104f: redundant information; skip ‘…[17, 18] but no GPCRs…..In nematodes…’

l.109: introduce ‘…human (homo sapiens) Hsa5-HT1b …’

l.115-117: redundant to information given in lines 110-114; skip

l.152f: the authors state that they prepared working dilutions of 5-HT in RPMI medium. Later they state that ligands were applied in assay buffer. Check and correct accordingly.

l.274: ‘…cloning…’ has been achieved after PCR amplification of cDNA fragments but not sequencing!

l.295: ‘…BLAST searches…’

l.299: ‘…denaturation…’

l.302: final extension for 2 mins?

l.311ff: shorten and rephrase para: e.g. ‘The cloned cDNA from E. canadensis was named Eca-5-HT1a….’

l.351ff: explain in more detail the assay conditions. What is a ‘G�s mutant’? For what purpose is it applied? How does it enter cells? Was IBMX used? Was Forskolin applied? Did the authors really add 500mM Na butyrate?

l.457: skip ‘…the mRNA or transcript…’

l.458: change to ‘…encoding the E. granulosus orthologue of this receptor…’

l.467: change to ‘…within the 5-HT1 clade (Fig. 1A) were named Eca-5-HT1a,…’

l.471: change to ‘…receptors identified in this work’

Figure1 and Figure legend:

There should be no N-glycosylation sites labelled in ICL3!

Why was TM1 excluded from the alignment?

The authors should give names and accession numbers of all receptor sequences in the Fig. legend.

l.473: change to ‘The structural representation…’

l.496ff: skip (clades 4, 7, 1) from legend; misleading because the authors only show three branches. Did the authors use an outgroup for calculating the phylogenetic tree?

l.509: skip ‘Overall…’

l.511: skip ‘…(like 5-HT or other ligands),…’

l.512: change to ‘The new…grouped within the 5-HT1 clade of serotonergic receptors in the phylogenetic tree (Fig. 1C).’

l.520: change to ‘Similar to Eca-5-HT1a, multiple sequence alignments…’

l.522: change to 61.2 kDa

l.526: change to ‘…within the 5-HT1 clade…’

l.530ff: change to: ‘However, this annotated receptor was not examined experimentally.’

l.533: change to ‘For labelling important aa residues, the Ballesteros…’

l.547: change to ‘Table 1 summarizes…’

l.549: change to ‘Corresponding residues in invertebrate…’

l.555f: skip ‘and classification’

l.570: change to ‘…5-HT2 type receptors.’

l.575: change to ‘ the Eca-5-HT1b receptor harbors a serine…’

l.580f: change to ‘The presence of threonine at position 5.39, a residue…’

l.590ff: change to ‘In the PIF motif…., the isoleucine (..) is replaced by a threonine in all three cloned…’

l.601: change to ‘Residues potentially involved in receptor and G-protein coupling’

l.613: change to ‘…GPCR groups…’

l.620ff: Table 3 is non-informative at all and should skipped. Spacing between residues located in different TMs is strongly influenced by the lengths of intervening loops. The only interesting aspect one might gain, is that many Gi-coupled receptors possess short C-termini, a feature also seen for the cestode receptors.

l.637f: phrase more patiently, a bioinformatics analysis of potential interacting G-protein subtypes should not be over-emphasized. For all receptors decent interaction with Gi-proteins is evident.

l.655: change to ‘…have a similar structure as Hsa-5-HT1b…’

l.701: give aa residues found at indicated positions

l.703: change to ‘The isoleucine at position…’

l.710ff: substitute’big’ for long

l.715ff: skip whole para; Eca-5-HT1b has not been examined experimentally in the contribution and the para duplicates results already summarized for the other receptors.

l.732: change to: ‘Addition of serotonin to cells transfected with the Eca-5-HT1a construct induced calcium release from intracellular stores in a concentration dependent manner (Fig…)’

l.737: change to ‘Heterologous expression of Eca-5-HT1a receptors’

l.738ff: Figure legend must be rephrased once corrections and additional experiments were included in Fig.3

l.756ff: statement is wrong and misleading! See my general comments. The authors must provide new data on the receptor : G-protein interaction. G15 is not a proper control!

l.760: skip ‘…(neurotransmitters…others)…’

l.761: Histamine also leads to an increase of the Ca++ dependent signal. Please explain!

l.762ff: whole para is not convincing as outlined in my general comments. The authors have to address the ability of Eca-5-HT1a to inhibit cAMP production by a series of novel experiments.

L768f: Misleading statement! So far, the authors have only in-appropriately examined coupling of Eca-5-HT1a to other G-proteins. As it reads, even in E. canadensis, the receptor would require G15 as an interacting partner to become functional.

l.775-781: rephrase and skip all informations already given in Mat. and Meth.

l.800: ‘…shown in F…’

l.807: ‘…shown in H…’

l.836f: change to ‘…receptor-containing fibers could receive serotonergic…’

l.847: change to: ‘…assignment the proteins as a 5-HT1 type receptors…’

l.851: skip info about spacing between TMs

l.858: change to ‘…is expected to be coupled…’

l.862ff: statement concerning coupling to Gi-proteins not sufficiently examined (s.a.); skip

l.887-910: whole para suffers from the in-appropriately executed experiments! Conclusions are not supported by current data.

l.916: change to: ‘…images shown…to release serotonin that could be…’

l.923: change to: ‘…low titers and high concentrations of the serotonin…’

l.936: change to: ‘…Sm-5-HTR was expressed…’

l.946f: skip ‘…, a serotonergic receptor…[57].’

l.951-956: shorten para because until now UCM2550 has not been proven to be active at Eca-5-HT1a.

l.961: change to ‘…receptor transcripts…’

l.963: change to: ‘…expression in the…stage is interesting…’

l.970ff: rephrase last sentence – strengthen wording

l.980: change to ‘…repurposing any of the approved drugs…’

l.1344: change to ‘…GPCR genes…’; most likely heading will be no more required when moving receptor names and accession numbers to legend of Fig.1.

l.1266: change to ‘Comparison of gene expression levels, determined…’

Figure S2: skip labelling of N-glycosylation sites in ICL3

Figure S4: skip completely

Figure S5: skip completely; seriously, part D does not fit to the data shown in the main text!

Figure S6: skip completely; as mentioned above, the data were obtained under in-appropriate conditions

Reviewer #2: This manuscript describes the detailed structural analysis and functional characterisation of a new type of cestode 5HT receptor. Multiple different methods were used to characterise the receptor including in silico analysis, expression in HEK cells and immunolocalization. Authors concluded that the 5HT receptor is likely be classified as type 1.

The real strengths of this manuscript lie in the comprehensive structural analysis of the receptors identified with very strong data indicating type 1 characterisation. The authors have appropriately addressed technical difficulties common with functional expression of receptors in HEK cells and provided more than sufficient data to prove that the receptor functions as a serotonin receptor. Although authors could not definitively functionally characterise this 5HT receptor as type 1, this is reflected appropriately in the final conclusion of the study and the language used when describing the receptor. The results have been condensed and presented in a very clear format highlighting the most important data within the study. Immunolocalization images are easy to interpret showing appropriate expression patterns for the conclusions which have been drawn from the study. Although background staining using the serotonin antibody is obvious, the authors have addressed this issue within the manuscript/review process and the staining presented for the 5HT receptor antibody is very clear and much more defined. Combined serotonin and 5HT receptor staining is acceptable for the conclusions drawn using this data.

Overall I believe this manuscript should be accepted for publication as the authors have made an impressive effort to address all issues/concerns from reviewers and really focussed the details of the study. The data presented are accurate supporting the discussions/conclusions and the manuscript has been edited to a very high standard.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Nov 11;16(11):e0259104. doi: 10.1371/journal.pone.0259104.r003

Author response to Decision Letter 0


16 Sep 2021

September 16, 2021

Dear Editor and Reviewers,

We are grateful for all your constructive input into our manuscript and will, in the following pages, provide answers to your questions and concerns. A revised manuscript, including tracked changes, as well as a final version, are attached to the submission.

Sincerely yours,

Dr Mara C. Rosenzvit

IMPAM-UBA-CONICET, Facultad de Medicina - Universidad de Buenos Aires Paraguay 2155, piso 13 (1121) Buenos Aires – ARGENTINA

Tel: (5411) 5950-9500 ext. 2192 Fax: (5411) 5950-9577

E-mail: mrosenzvit@fmed.uba.ar; mararosenzvit@gmail.com

Professor Dr. Jonathan S. Marchant

Marcus Professor & Chair

Department of Cell Biology, Neurobiology & Anatomy 8701 Watertown Plank Road

Post Office Box 26509

Milwaukee, Wisconsin 53226-0509

Tel: (414) 955-8261

Fax: (414) 955-6517

jmarchant@mcw.edu

¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Camicia et al. provide a revised version of their manuscript that I had not evaluated in the first round of the reviewing process. The authors have conducted a molecular and bioinformatics approach and identified potential members of the serotonin (5-HT) 1 clade of G-protein coupled receptors in E. canadensis, M. vogae, and H. microstoma. Classifiction of the receptor proteins is mainly based on bioinformatic evidence. The manuscript in general is valuable and extends current knowledge on the repertoire of biogenic amine receptors expressed in platyhelminthes. The bioinformatics part of study has been conducted with high precision and depth. However, certain aspects especially the pharmacological characterization of the receptors require further experimental investigation to unequivocally support classifying the receptors as 5-HT1 clade members. My general and specifc comments are outlined in the following paragraphs.

General comments

Throughout the manuscript the authors should strictly use the conventional nomenclature used by the ‘serotonin receptor community’: serotonin (= 5-hydroxy tryptamine, 5-HT) and subscript for receptor sub-families: 5-HT1.

Another fail in spelling should be corrected: use G-protein coupled receptors (GPCRs) as well as G-proteins throughout the manuscript.

Substitute ‘dose(s)’ for concentration(s); and use the term ‘concentration-response curve’.

Thank you very much for this feedback. We have included the conventional nomenclature to refer to serotonin all along the manuscript. We also included the subscript for each receptor sub-family. We have also included the terms “G-protein coupled receptor” as well as “G-proteins” in the manuscript. The term “dose(s)” was replaced by “concentration(s)”. Finally, we included the term “concentration-response curve”.

A main issue of concern, however, goes to the pharmacological data provided in the manuscript. It is a common and well-taken approach to study, e.g., a newly cloned receptor gene in a ‘reporter’ cell line. For this purpose the authors have chosen cells that constitutively express a promiscuous G-protein (G15). This is a smart experimental design to gain first insight into a receptor’s functionality. However, the data shown in Fig. 3A and 3B raise certain doubts and are (in part) incorrect:

a) in Fig. 3A the concentration is missing. I guess it is µM(?).

Thank you for spotting this error. Yes, the concentration is in µM and this was changed in the new revised graph.

b) scaling of the ordinate is inappropriate (omit negative values; in 3B, too) and has to be changed.

The ordinates from figures 3A and 3B have been changed as requested.

c) exposure/measuring time for cell-based Ca++ fluorescent assays would be extremely long according to the values given on the abscissa (approx. 80 min total measuring time). In the Mat. and Meth. section, the authors state that measurements were performed in scales of seconds. What is correct? I assume, as typical for Ca++ imaging experiments, the latter and, thus, the graph requires editing.

We didn´t realize about this mistake in our previous submission. The measurements were performed in scales of seconds and the graphs have been edited accordingly.

d) The authors state that Fig.3A contains raw data. This does not fit to Mat. and Meth. (l.337ff) and it would be better to display the graphs either as �RFU vs time or as �RFU/R0 (= mean basal fluorescence) vs time.

The data represent raw fluorescence units, and we feel there is merit in presenting raw data. ΔF/Fo is approximately 12 for maximal responses (to 5-HT) under our assays conditions with fluo-4 as the reporter.

e) How do the authors explain that fluorescent signals decrease approx. 40 min (sec?) after 5-HT application for almost all ligand concentrations, except for 50µM?

Thank you for this observation. As this reviewer states, the fluorescent signal of almost all ligand concentrations decrease after 40 seconds, even for peak 5-HT concentrations (50µM). For example, see the following graph: at longer times, it can be seen that also, at 50 µM of 5-HT the fluorescent signal decreases too. This is because in intact cells, elevated cytoplasmic Ca2+ is removed from the cell by extrusion across the cell surface/endoplasmic reticulum membranes away from the cytosolic reporter. As the reviewer may be implying this could well imply a desensitization in the cestode GPCR responsiveness to maximal 5-HT, as observed in many GPCR systems. Further studies would be needed to investigate the molecular basis underpinning this effect.

Figure 1: Time resolved measurements of Ca2+ accumulation (measured as change in relative fluorescence units, ΔRFU) in cells expressing the cestode Eca-5-HT1a receptor before and after addition of different concentrations of 5-HT (arrow, concentrations indicated in legend).

f) Which concentrations (5-HT) were used to calculate the concentration-response curve displayed in Fig.3B? Labeling of the ordinate seems to be wrong (5-HT µM). I guess it is (M), otherwise the deduced EC50 would be six orders of magnitude smaller than given in the manuscript (~7.7 nM). Data points for (0µM) 5-HT are missing! Have they been assigned to 10-11µM 5-HT? This should be changed and the graph adapted accordingly. Furthermore, instead of 100µM (=10-4M) 5-HT, the highest concentration of 5-HT shown in Fig.3A and also stated in Mat. and Meth. was 50µM (=5x10-4M). Therefore, the graph has to be corrected also in this respect.

Thank you very much for this observation. The labeling of the ordinate was wrong and changed to Molar (M). Data points for zero concentrations were now included in the graph. The highest concentration of 5-HT for the new revised graph was 100 µM (= 1 x 10-4 M) as mentioned. The graph was changed following the suggestions made by the reviewer.

g) Fig.3C should be exchanged for a bar graph in which the normalized peak values of fluorescence are displayed and, eventually, negative values might be defined as 0. It would have been also more appropriate to use identical ligand concentrations (here 10 µM) in all measurements and the authors should provide these data. Can the authors explain why histamine application causes a fluorescent signal?

We have changed Figure 3C as suggested and have also incorporated parallel measurements in control cells (not expressing the GPCR). For symmetry we have now included identical concentrations of all ligands (10uM).

As can been seen in the new data, the tiny responsiveness to histamine is also seen in control HEK293-GNA15 cells, suggesting the expression of endogenous histamine receptors in the HEK293-GNA15 cell line. For this reason, the fluorescent signal observed initially with histamine not seems to be relevant in the study of the Eca-5-HT1a receptor specificity.

h) The experiments performed to examine the potential coupling of the receptor to cAMP signalling suffer from faulty experimental design. Given that the receptor belongs to the 5-HT1 subfamily, the most obvious assumption were, that receptor activation leads to a reduction of the intracellular cAMP concentration. To assess this effect experimentally, cells have to be incubated with (1) IBMX to block PDE activities and (b) with forskoin or its derivative (NKH477) to stimulate endogenous membrane-bound adenylyl cyclases. In this way, one would gain an increase in cAMP. Upon adding a concentration series of 5-HT, the authors should be able to register a reduction of the cAMP concentration – leading to a nice and convincing demonstration of the correct assignment of the receptor. The authors may employ their (cAMP)-reporter cell assay referred to in the manuscript for this purpose or use a commercial kit to determine cAMP concentrations. Without such data, the value of the manuscript is considerably reduced.

Based on the reviewer’s feedback, we have removed these experiments from the manuscript as these negative data do not add to the narrative. We tried to demonstrate changes in cAMP signaling using the cADDis system, but were unsuccessful. The methodology however was appropriate to elevate cAMP, as a constitutively active Gαs was introduced into cells (as per manufacturer’s optimization) (1, 2).

Instead, we now provide new data with a suite of point mutations around the 5-HT binding pocket that provide further evidence that mutation of residues known to coordinate 5-HT ablate the function of the cestode GPCR (new Figure 3D, lines 1174-1205 of the new revised version with marked changes). Further research into the mechanisms of parasite GPCR/mammalian G proteins are needed to solve the problem of coupling.

Given that we were unable to experimentally confirm if Eca-5-HT1a is indeed 5-HT1 type of receptors, we moderated the strength of the affirmations/conclusions related to receptor classification in the abstract, results and discussion sections. We employed the terms “likely”, “presumptive” and/or “putative” all along the article when we talk about receptor assignment to a specific clade. Coupling specificity is only suggested here based on receptor´s phylogenetic and structural data.

However, based in phylogenetics, alignments and modeling studies we hypothesize here the existence of receptors belonging to another type to those already described in our previous publication (3). We believe that the findings reported here (in case they were disseminated) will open the door and will encourage to other researchers to search new receptors in this phylum. The lack of coupling observed here (between the cestode receptor and the mammalian Galphai/o protein subunit), far from being uninteresting could instead mean a different (and very interesting) mechanism of interaction between the cestode receptor and their native G alpha i/o coupling partner.

In the context of the experimental pharmacology in parasites, in which novel targets and drugs are urgently needed to treat zoonotic diseases (like cystic echinococcosis for example) and the absolute lack of information about this type of receptors in this phylum (where only 5-HT7 receptors were described so far), the structural peculiarities of the newly discovered receptor, and more interesting, the localization of this receptor in the nervous system of the parasite (perhaps well known in other invertebrate species like insects but not in Platyhelminths) are key aspects that should be further considered for publication. The situation is very different for example in the context of the insect receptor biology in which many receptors of the 5-HT1 clade and other major families of serotonin receptors where already described.

References:

1-Manual, catalog number #X0200G from Montana Molecular. https://montanamolecular.com/product/x0200g-green-gi-caddis-camp-assay-kit/

2-Tewson P, Martinka S, Shaner N, Berlot C, Quinn AM, Hughes T. Assay for Detecting Gαi-Mediated Decreases in cAMP in Living Cells. SLAS Discov. 2018 Oct;23(9):898-906.

3- Camicia F, Celentano AM, Johns ME, Chan JD, Maldonado L, Vaca H, Di Siervi N, Kamentezky L, Gamo AM, Ortega-Gutierrez S, Martin-Fontecha M, Davio C, Marchant JS, Rosenzvit MC. Unique pharmacological properties of serotoninergic G-protein coupled receptors from cestodes. PLoS Negl Trop Dis. 2018 Feb 9;12(2):e0006267.

i) A final concern addresses the pharmacological profile of the receptor. The authors state that potential agonists did not or only scarcely induce receptor activity. However, the authors should examine and provide data on the effects of antagonists, too. They may select characteristic ones from the rich source of compounds that are known to interact with 5-HT1 receptors in a variety of other species, including insects. It should be rather straightforward to use the Ca++ imaging set-up to perform such experiments.

In the new revised version of the manuscript, we have included an entire new section devoted to Eca-5-HT1a pharmacology (please see lines 1207-1231 of the new revised version with marked changes). During the course of the new experiments performed, we have found by chance a new 5-HT GPCR agonist called tryptamine. The response to tryptamine seems to be strong but lower than to 5-HT (Fig 3 C). The agonist activity observed in Eca-5-HT1a resulted interesting since tryptamine was shown inactive in the insect Trica5-HT receptor (an invertebrate 5-HT1 GPCR described in the red flour beetle (Tribolium castaneum) suggesting interesting pharmacological differences between invertebrate receptors (1).

The 5-HT GPCRs agonists 5-methoxytryptamine and α-methylserotonin displayed concentration-response activity in a stable cell line expressing the Eca-5-HT1a receptor (Fig 4A).

Moreover, we have found that methysergide display strong inhibitory activity using the same stable cell line (Fig 4B). This compound has shown inhibitory activity in other invertebrate 5-HT1 receptors, e.g. Trica5-HT suggesting that Eca-5-HT1a could be a 5-HT1 receptor type (1).

1-Vleugels R, Lenaerts C, Baumann A, Vanden Broeck J, Verlinden H (2013) Pharmacological Characterization of a 5-HT1-Type Serotonin Receptor in the Red Flour Beetle, Tribolium castaneum. PLoS ONE 8(5): e65052. https://doi.org/10.1371/journal.pone.0065052

Specific comments

l.38: ‘…GPCR motifs…’

Suggestion included in the text, line 57.

l.40: as stated above change nomenclature to Eca-5-HT1a

The original name of the receptor (Eca-5HT1a) was changed for (Eca-5-HT1a) in all the manuscript, figures and supplementary material as suggested.

l.88: change to: ‘…5-HT receptors are known but…’

Suggestion included in the text, line 117.

l.90f: skip ‘…determined by similarities in sequence and transduction mechanisms [ ]’

Suggestion included in the text, line 119.

l.92: ‘…system exists based…’

Removed with the sentence, line 120.

l.92-94: referring to C.elegans assignment of 5-HT clades is more confusing than helpul. Skip sentence.

Removed as suggested, line 120.

l.95ff: re-order sentences; starting with 5-HT1 receptors and ending with 5-HT7-like receptors.

The sentences were re-ordered as suggested, see lines 120 to 140.

l.104f: redundant information; skip ‘…[17, 18] but no GPCRs…..In nematodes…’

Removed as suggested, line 144.

l.109: introduce ‘…human (homo sapiens) Hsa5-HT1b …’

Introduced as suggested, line 148.

l.115-117: redundant to information given in lines 110-114; skip

Removed from the text as suggested, line 154.

l.152f: the authors state that they prepared working dilutions of 5-HT in RPMI medium. Later they state that ligands were applied in assay buffer. Check and correct accordingly.

Working dilutions were prepared in RPMI medium. The word “assay buffer” was changed by “RPMI” in line 449.

l.274: ‘…cloning…’ has been achieved after PCR amplification of cDNA fragments but not sequencing!

The word sequencing was removed from this sentence in line 373 as suggested.

l.295: ‘…BLAST searches…’

The plural form of the word BLAST was removed as suggested in line 400.

l.299: ‘…denaturation…’

The word was corrected as suggested in line 404.

l.302: final extension for 2 mins?

The right final extension step was of 30 minutes and included in line 407.

l.311ff: shorten and rephrase para: e.g. ‘The cloned cDNA from E. canadensis was named Eca-5-HT1a….’

Shortened and rephrased as suggested in lines 415-416.

l.351ff: explain in more detail the assay conditions. What is a ‘G�s mutant’? For what purpose is it applied? How does it enter cells? Was IBMX used? Was Forskolin applied? Did the authors really add 500mM Na butyrate?

The assay conditions were the following: cAMP Gi assay was performed in live cells using the green difference detector in situ (cADDis) cAMP sensor (Montana Molecular, Bozeman, MT) (1). HEK‐293 or HEK-293 transiently transfected with Eca-5-HT1a cells were plated on a black‐walled, clear flat bottom 96‐well plates along with 20-25 µl of cADDis sensor, 4 µM Gαs mutant, 500 mM Sodium butyrate in Dulbecco's Modified Eagle Medium with 10% FBS. Alternatively, hD2 receptor was used as a control instead of Eca-5-HT1a. 24 hr after incubation at 5% CO2 and 37°C, Media was aspirated and replaced with the culture media containing 100 µl per well of 1X Dulbecco's Phosphate Buffered Saline Solution with calcium and magnesium. Then, the 96‐well plate was covered with aluminum foil and incubated at room temperature for 30 minutes. Cell fluorescence was read from the plate bottom using 485 nm of excitation and 535 nm of emission wavelengths using a SpectraMax i3X plate reader (Molecular Devices). Basal fluorescence was monitored for 5 minutes, then serotonin was added, and the fluorescence signal (raw fluorescence units) was monitored for an additional 30 minutes with 30 seconds intervals. For quantitative analyses, peak fluorescence was further analyzed in Origin.

The cADDis assay decreases fluorescence intensity when cAMP is increasing in the cell and increases in fluorescence in response to activation of Gαi (1,2). To detect the activation of Gαi, the steady state levels of cAMP should first be increased with the constitutively active Gαs provided in the kit (1,2). The G�s mutant is a constitutively active G alpha protein which increases steady-state levels of cAMP and eliminates the need to add forskolin (3). This gene enters the cell by transduction together the cAMP sensor.
The response of the control receptor hD2 observed strongly suggest that the whole experiment was properly performed.

References:

1-Manual, catalog number #X0200G from Montana Molecular. https://montanamolecular.com/product/x0200g-green-gi-caddis-camp-assay-kit/

2-Tewson P, Martinka S, Shaner N, Berlot C, Quinn AM, Hughes T. Assay for Detecting Gαi-Mediated Decreases in cAMP in Living Cells. SLAS Discov. 2018 Oct;23(9):898-906.

3-Grishina G, Berlot CH. Identification of common and distinct residues involved in the interaction of alphai2 and alphas with adenylyl cyclase. J Biol Chem. 1997 Aug 15;272(33):20619-26.

l.457: skip ‘…the mRNA or transcript…’

The indicated words were removed as suggested, line 517.

l.458: change to ‘…encoding the E. granulosus orthologue of this receptor…’

Changed as suggested, line 518.

l.467: change to ‘…within the 5-HT1 clade (Fig. 1A) were named Eca-5-HT1a,…’

Changed as suggested, line 526.

l.471: change to ‘…receptors identified in this work’

Changed as suggested, line 540.

Figure1 and Figure legend:

There should be no N-glycosylation sites labelled in ICL3!

Thank you for this observation. Labels for N-glycosylation sites in ICL3 were removed from the figure.

Why was TM1 excluded from the alignment?

In most of the reviewers about serotonergic GPCRs, the first TM1 is not usually mentioned. In our previous submission, we thought that the inclusion of this domain could disperse or distract the reader about which part of the sequence should first look at. However, this time, we have included this domain in the new version of the figure following reviewer suggestion.

The authors should give names and accession numbers of all receptor sequences in the Fig. legend.

Names and accession numbers of all sequences were included in the new revised version. Lines 541 to 542, 551 to 570, 581 to 591 and 707.

l.473: change to ‘The structural representation…’

Changed as suggested, line 543.

l.496ff: skip (clades 4, 7, 1) from legend; misleading because the authors only show three branches. Did the authors use an outgroup for calculating the phylogenetic tree?

Clades removed as suggested, line 701-702. We have included an outgroup for calculating the phylogenetic tree.

l.509: skip ‘Overall…’

Removed as suggested, line 716.

l.511: skip ‘…(like 5-HT or other ligands),…’

Removed as suggested, line 717.

l.512: change to ‘The new…grouped within the 5-HT1 clade of serotonergic receptors in the phylogenetic tree (Fig. 1C).’

Changed as suggested, lines 718-720.

l.520: change to ‘Similar to Eca-5-HT1a, multiple sequence alignments…’

Changed as suggested, lines 725-741.

l.522: change to 61.2 kDa

Changed as suggested: comma replaced by dot, line 742.

l.526: change to ‘…within the 5-HT1 clade…’

Changed as suggested, lines 745-746.

l.530ff: change to: ‘However, this annotated receptor was not examined experimentally.’

Changed as suggested, line 749.

l.533: change to ‘For labelling important aa residues, the Ballesteros…’

Changed as suggested, line 750.

l.547: change to ‘Table 1 summarizes…’

Changed as suggested, line 782.

l.549: change to ‘Corresponding residues in invertebrate…’

Changed as suggested, line 783-784.

l.555f: skip ‘and classification’

Removed as suggested, line 790.

l.570: change to ‘…5-HT2 type receptors.’

Changed as suggested, line 841.

l.575: change to ‘ the Eca-5-HT1b receptor harbors a serine…’

Changed as suggested, line 846.

l.580f: change to ‘The presence of threonine at position 5.39, a residue…’

Changed as suggested, line 852.

l.590ff: change to ‘In the PIF motif…., the isoleucine (..) is replaced by a threonine in all three cloned…’

Change as suggested, lines 868-870.

l.601: change to ‘Residues potentially involved in receptor and G-protein coupling’

Change as suggested, lines 879.

l.613: change to ‘…GPCR groups…’

Removed with the Table 3.

l.620ff: Table 3 is non-informative at all and should skipped. Spacing between residues located in different TMs is strongly influenced by the lengths of intervening loops. The only interesting aspect one might gain, is that many Gi-coupled receptors possess short C-termini, a feature also seen for the cestode receptors.

Removed as suggested. We think that both: short C-termini and long intracellular loop are major structural aspects characteristic of Gi-coupled receptors. The long intracellular loop is another important structural feature of Gi-coupled receptors that, to the best of our knowledge, should not be underrated.

l.637f: phrase more patiently, a bioinformatics analysis of potential interacting G-protein subtypes should not be over-emphasized. For all receptors decent interaction with Gi-proteins is evident.

We changed and moderated our affirmations, lines 940-941.

l.655: change to ‘…have a similar structure as Hsa-5-HT1b…’

Changed as suggested, line 984.

l.701: give aa residues found at indicated positions

Added as suggested, line 1050.

l.703: change to ‘The isoleucine at position…’

Changed as suggested, line 1052.

l.710ff: substitute’big’ for long

Changed as suggested, line 1058.

l.715ff: skip whole para; Eca-5-HT1b has not been examined experimentally in the contribution and the para duplicates results already summarized for the other receptors.

Removed as suggested.

l.732: change to: ‘Addition of serotonin to cells transfected with the Eca-5-HT1a construct induced calcium release from intracellular stores in a concentration dependent manner (Fig…)’

Changed as suggested, line 1080.

l.737: change to ‘Heterologous expression of Eca-5-HT1a receptors’

Change as suggested, line 1084.

l.738ff: Figure legend must be rephrased once corrections and additional experiments were included in Fig.3

Change as suggested, line 1084 to 1164.

l.756ff: statement is wrong and misleading! See my general comments. The authors must provide new data on the receptor : G-protein interaction. G15 is not a proper control!

As we explain before, downward cADDis experiments (permutated probe which responds to cAMP decreases with fluorescence increases) seem to show that the cestode receptor don´t couple with the endogenous mammalian G alpha i/o subunit. We are sure that this could not be attributed to a lack of technical skills since mammalian positive control is responding.

We already realized that unfortunately, in spite of the big effort invested, we were only able to prove here receptor activation but not receptor coupling. The transfection without G15 is a necessary control to exclude Gq endogenous coupling since both G alpha subunits, Galpha15 and Galphaq give intracellular increases in calcium levels.

In the light of the results obtained, we wonder if the lack of productive interaction between cestode receptor and mammalian G alpha i/o subunit means that this interaction is not conserved or is divergent in Platyhelminths. This latter hypothesis far from uninteresting could have interesting implications from the perspective of parasite pharmacology.

l.760: skip ‘…(neurotransmitters…others)…’

Removed as suggested.

l.761: Histamine also leads to an increase of the Ca++ dependent signal. Please explain!

We observed a very slight increase over basal levels in the Ca++ dependent signal in the presence of histamine at 10 µM which was lower than that observed with serotonin, which was 3 fold times higher than basal levels at serotonin concentrations of 10 µM. As can been seen in the new data (Fig 3C), the responsiveness to histamine is also seen in control HEK293-GNA15 cells, consistent with the known expression of histamine responses in the HEK293-GNA15 cell line.

l.762ff: whole para is not convincing as outlined in my general comments. The authors have to address the ability of Eca-5-HT1a to inhibit cAMP production by a series of novel experiments.

The experiments suggested were performed and explained above but no inhibition in cAMP production could be detected. The experiments performed with the promiscuous G protein only suggest receptor activation but don´t give cues regarding coupling specificity. Receptor classification is only suggested here based on receptor´s phylogenetic and structural data and this was clearly explained in the discussion section. The lack of interaction between cestode receptor and mammalian G alpha protein, far from uninteresting, could mean a novelty in the way that Platyhelminths transduce signals and could have implications in the Parasite Pharmacology.

L768f: Misleading statement! So far, the authors have only in-appropriately examined coupling of Eca-5-HT1a to other G-proteins. As it reads, even in E. canadensis, the receptor would require G15 as an interacting partner to become functional.

We have removed the whole paragraph as suggested to avoid confusion. As we already explained previously in this response, coupling was analyzed by the downward cADDis system without success. As it was clearly stated in the discussion section (please see lines 1330 to 1335), coupling specificity is only suggested here based on receptor´s phylogenetic and modeling data.

l.775-781: rephrase and skip all informations already given in Mat. and Meth.

Removed to avoid redundancy with the information given in Math & Meth and rephrased in lines 1236-1240.

l.800: ‘…shown in F…’

Changed as suggested, line 1271.

l.807: ‘…shown in H…’

Changed as suggested, line 1278.

l.836f: change to ‘…receptor-containing fibers could receive serotonergic…’

Changed as suggested, line 1308.

l.847: change to: ‘…assignment the proteins as a 5-HT1 type receptors…’

Change as suggested, line 1331.

l.851: skip info about spacing between TMs

Removed as suggested, line 1335.

l.858: change to ‘…is expected to be coupled…’

Change as suggested, line 1336.

l.862ff: statement concerning coupling to Gi-proteins not sufficiently examined (s.a.); skip

As we have explained previously, we have examined this issue using the downward cADDis system which couples the cAMP decreases with increases in fluorescence. Anyway, we have followed the review suggestion and the entire paragraph was removed as suggested, line 1339.

l.887-910: whole para suffers from the in-appropriately executed experiments! Conclusions are not supported by current data.

Thank you for this suggestion. We believe that we were unclear in our previous submission and the cADDis experiment was not properly described previously. Again, we have used the downward cADDis system which couples the cAMP decreases with increases in fluorescence. To detect cAMP decreases, the basal levels of cAMP were first increased with the constitutive Galphas mutant protein. Functional studies performed with the promiscuous Galpha15 protein only demonstrate activation of the receptor but not coupling. As it was clearly stated in the discussion section (please see lines 1330 to 1335), the evidence for the presumptive assignment the proteins as a 5-HT1 type of receptors are 1) phylogenetic analysis, 2) presence of residues in the ligand-binding pocket that are characteristic of 5-HT1 type, 3) presence of putative G-protein coupling residues (selectivity determinants of the receptor) that are more similar to the 5-HT1 type than to other clades, and finally, 4) structural features typical of 5-HT1 type of receptors.

l.916: change to: ‘…images shown…to release serotonin that could be…’

Changed as suggested, please see lines 1463 and 1465.

l.923: change to: ‘…low titers and high concentrations of the serotonin…’

Changed as suggested, line 1470.

l.936: change to: ‘…Sm-5-HTR was expressed…’

Changed as suggested, line 1483.

l.946f: skip ‘…, a serotonergic receptor…[57].’

Section deleted as suggested, line 1502.

l.951-956: shorten para because until now UCM2550 has not been proven to be active at Eca-5-HT1a.

All the paragraph was deleted as suggested, line 1503.

l.961: change to ‘…receptor transcripts…’

Changed as suggested, line 1508.

l.963: change to: ‘…expression in the…stage is interesting…’

Changed as suggested, line 1510.

l.970ff: rephrase last sentence – strengthen wording

Rephrase as suggested, lines 1517 to 1569.

l.980: change to ‘…repurposing any of the approved drugs…’

Change as suggested, line 1577.

l.1344: change to ‘…GPCR genes…’; most likely heading will be no more required when moving receptor names and accession numbers to legend of Fig.1.

Removed as suggested.

l.1266: change to ‘Comparison of gene expression levels, determined…’

Change as suggested, line 1956.

Figure S2: skip labelling of N-glycosylation sites in ICL3

The labelling of N-glycosylation sites was removed from the figure as suggested.

Figure S4: skip completely

Removed as suggested.

Figure S5: skip completely; seriously, part D does not fit to the data shown in the main text!

Removed as suggested.

Figure S6: skip completely; as mentioned above, the data were obtained under in-appropriate conditions

Removed as suggested.

Reviewer #2: This manuscript describes the detailed structural analysis and functional characterisation of a new type of cestode 5HT receptor. Multiple different methods were used to characterise the receptor including in silico analysis, expression in HEK cells and immunolocalization. Authors concluded that the 5HT receptor is likely be classified as type 1.

The real strengths of this manuscript lie in the comprehensive structural analysis of the receptors identified with very strong data indicating type 1 characterisation. The authors have appropriately addressed technical difficulties common with functional expression of receptors in HEK cells and provided more than sufficient data to prove that the receptor functions as a serotonin receptor. Although authors could not definitively functionally characterise this 5HT receptor as type 1, this is reflected appropriately in the final conclusion of the study and the language used when describing the receptor. The results have been condensed and presented in a very clear format highlighting the most important data within the study. Immunolocalization images are easy to interpret showing appropriate expression patterns for the conclusions which have been drawn from the study. Although background staining using the serotonin antibody is obvious, the authors have addressed this issue within the manuscript/review process and the staining presented for the 5HT receptor antibody is very clear and much more defined. Combined serotonin and 5HT receptor staining is acceptable for the conclusions drawn using this data.

Overall I believe this manuscript should be accepted for publication as the authors have made an impressive effort to address all issues/concerns from reviewers and really focussed the details of the study. The data presented are accurate supporting the discussions/conclusions and the manuscript has been edited to a very high standard.

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Response to the reviewers.docx

Decision Letter 1

Wolfgang Blenau

13 Oct 2021

Characterization of a new type of neuronal 5-HT G-protein coupled receptor in the cestode nervous system

PONE-D-21-12202R1

Dear Dr. Camicia,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Wolfgang Blenau

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Lines 540-542, ”The nucleotide 541 sequence from this E. canadensis cDNA was 1638 base pairs long with an open reading frame of 1638 bp”: Is the value 1638 bp correct for both, cDNA length and ORF? Please check!

Line 786, “concetration”: Please correct typo!

Reviewers' comments:

Acceptance letter

Wolfgang Blenau

28 Oct 2021

PONE-D-21-12202R1

­­Characterization of a new type of neuronal 5-HT G- protein coupled receptor in the cestode nervous system

Dear Dr. Camicia:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Wolfgang Blenau

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Antigen analysis by western blot and antibody titer evaluation by ELISA.

    A) Lane 1, GenScript protein marker (Cat. No. M00521); lane 2, 5 μg of Eca-5-HT1aICL3. The antigen was run in polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane. The membrane was probed with antibody against poly-histidine tag. The arrow shows the position of the band detected. B) The recombinant antigen produced was administered in six mice and then anti-Eca-5-HT1aICL3 antibody titers were evaluated by ELISA technique. End-point titer was calculated as the reciprocal of the dilution with an Absorbance 450 nm = 0.5. The antibody titers are indicated in the table from the right. “Pre” represents the specific antibody titer of pre-immunized mice.

    (TIF)

    S2 Fig. Transcriptional expression levels of serotonergic GPCRs genes in Echinococcus granulosus.

    Egr-5-HT1a, Egr-5-HT1b, Egr-5-HT7a and Egr-5-HT7b GPCRs transcriptional expression levels are shown as RPKM (Reads Per Kilobase Million). Comparison of gene expression levels, determined by RNAseq, in several developmental stages of Echinococcus granulosus sensu stricto (G1): Oncosphere, Cyst, Protoscolex and Adult [26]. The closest orthologue of the receptor studied here, Egr-5-HT1a, was marked in bold and the level of transcript expression of this receptor in the protoscolex stage was marked with an arrow. With exception of the protoscolex larval stage, no transcript expression was observed for this receptor in other stages of the parasite.

    (TIF)

    S3 Fig. Bioinformatic analyses of the hypothetical Eca-5-HT1b receptor.

    A. The bidimensional structure representation and prediction of residues of potential N-glycosylation of Eca-5-HT1b were obtained with the Protter program (http://www.enzim.hu/hmmtop/index.php). The intracellular and extracellular loops are indicated as ICL and ECL respectively. The third intracellular loop used for antibody generation is shaded in grey. Residues potentially involved in N-linked glycosylation were marked in green. B. The amino acid sequences of predicted serotonin receptors ortologues with best scores in blast searches with the cestode Eca-5-HT1b were aligned using the ClustalW method. The new 5-HT1 type cloned receptors’ names are marked in bold. The transmembrane (TM), intracellular (ICL) and extracellular (ECL) domains are indicated above each alignment. For the sake of simplicity, the amino terminal end, the transmembrane domain 1, the intracellular loop three and the carboxy terminal end were trimmed partially or completely. The position of residues involved in G protein coupling are indicated with asterisks below each alignment. Residues present in the new predicted receptors that were not seen in other GPCRs are underlined. Critical residues involved in ligand binding and receptor function were indicated in bold below each alignment. Cysteine residues potentially involved in disulphide bond formation are marked as S-S between cysteines. The receptor names, identification numbers and the corresponding species from which the receptors were obtained are enlisted in Table C from S1 Text.

    (TIF)

    S4 Fig. Structural comparative analysis between serotonergic type 1 and type 7 receptors.

    Comparative analysis of the general structures of the homology models to 5-HT1- vs 5-HT7-type serotonergic receptors from Echinococcus canadensis G7 (A) Eca-5-HT1a and (B) Eca-5-HT7a; and Homo sapiens (C) Hsa-5-HT1a and (D) Hsa-5-HT7a. In all the representations, the transmembrane domains I to VII (7-TM) were represented as cartoon while the intracellular loop 3 (ICL3) and C-terminus regions (C-term) were represented as surface. Note the smaller ICL3 and longer carboxy terminal end in 5-HT7-type receptors with respect to 5-HT1-type receptors, in which a bigger ICL3 and smaller C-term (marked as a short cartoon) can be seen.

    (TIF)

    S1 Table. G-protein coupling selectivity score for experimentally validated invertebrate 5-HT GPCRs.

    (DOCX)

    S1 Data. Excel spreadsheet containing, in separate sheets, the underlying numerical data for Fig 3A–3D, Fig 4A and 4B, and S1 Fig.

    (XLSX)

    S1 Raw image. Original image from the western blot provided by Genscript in the certificate of analysis of recombinant Eca-5-HT1aICL3.

    (TIF)

    S1 Text. Nucleotide and translated amino acid sequences of the third loop of Eca-5-HT1a.

    (DOCX)

    S2 Text. Parameters and Ramachandran plots for the structure models generated in this work.

    (DOCX)

    Attachment

    Submitted filename: Response to reviewers 2021 3 31.docx

    Attachment

    Submitted filename: Response to the reviewers.docx

    Data Availability Statement

    All the accession numbers are available from the Genbank database (accession number(s) MW535743 for Eca-5HT1a; MW535744 for Mvo-5HT1a and MW535745 for Hmi-5HT1a).


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES